Drug Health Services Research

The Edith Collins Centre (ECC) is a Translational Research in Alcohol Drugs and Toxicology, established to increase clinical research capacity in the alcohol, drugs and toxicology fields as a partnership between Sydney Local Health District and the University of Sydney.

Our multi-disciplinary research ranges from early interventions for drug and alcohol use, genetic and molecular mechanisms of tissue injury, clinical trials in the treatment of substance use disorders, and encompasses a broad range of disciplines including clinical toxicology, addiction medicine, public health, epidemiology, hepatology, mental health and Aboriginal and Torres Strait Islander health. The Centre comprises several highly successful research groups conducting nationally and internationally leading work in these areas, achieving world-first outcomes in their fields, including the establishment of notable international collaborations and consortia and large multi-national cohorts. The work is mainly supported by external peer-reviewed grants. ECC Staff Specialists also provide leadership and teaching in the Speciality of Addiction Medicine at the University of Sydney.

Specifically, our research is aligned across the following five key areas of research:

Clinical Toxicology and Pharmacology (Professor Andrew Dawson, Professor Nick Buckley, Associate Professor Darren Roberts)
Indigenous Health and Substance Use (Professor Kate Conigrave, Associate Professor Kylie Lee, Dr Michael Doyle)
Alcohol Biology, and Genetics of Liver Disease (Associate Professor Devanshi Seth, Professor Paul Haber)
Clinical Research in Alcohol, Addictive Behaviours & Treatment (Associate Professor Kirsten Morley, Professor Paul Haber, Professor Andrew Baillie, Dr Warren Logge)
Illicit Drug Use (Associate Professor Carolyn Day)

Drug Health Services Research has a number of Translational Research projects that aim to increase uptake of evidence-based treatment. These projects are funded by NHMRC and NSW Health and include: increasing uptake of evidence-based treatment for alcohol problems in Australia's First Peoples, improving the management of comorbid mental health and substance use with an integrated approach (including a multi-modal training package to several sites across NSW Health LHD's) and a shared care pathway for the treatment of alcohol use disorders in primary care.

Key Research Areas

Clinical Toxicology and Pharmacology

Indigenous Health and Substance Use

Alcohol Biology and Genetics of Liver Disease

Alcohol biology and genetics of liver disease is an important area of research at Drug Health Services within the Alcoholic Liver Disease Research Program. The program led by Associate Professor Devanshi Seth, undertakes a range of clinical, fundamental and translational research. This research is internationally recognised for significantly advancing the field by contributing to the understanding of genetics and molecular mechanisms of alcohol-related liver disease (ALD). Current research involves:

Clinical research: the multinational GenomALC Consortium led by Seth is investigating the genetic/genomic factors associated with the risk of alcoholic cirrhosis across Australia, UK, USA and Europe. The team established the world's largest biobank and database from ~6700 drinkers and identified novel genetic risks associated with alcohol-related cirrhosis. This ongoing research, funded by the National Institutes of Health (NIH)/National Institute on Alcohol Abuse & Alcoholism (NIAAA), USA, continues to explore the genetic architecture of this disease
Fundamental research: This research focuses on understanding the molecular mechanism underlying progression of ALD using experimental models, including animal (mouse, zebrafish) models of fatty liver. Research using state-of-the-art gene-editing tools (Crispr-Cas9) in a zebrafish model of alcohol-induced fatty liver is underway studying the mechanisms of action of the genes (identified through GenomALC findings) involved in lipid (fat) metabolism
Translational research: (i) The GenomALC study developed a novel genetic risk score (GRS) and combined with clinical risk (diabetes) developed a predictive model to identify patients at higher risk of cirrhosis. This novel concept is now being planned for a randomized clinical trial that underpins the implementation of this research with a potential to significantly impact the field of genomics and personalised medicine for ALD patients. (ii) PETH test, a semi-quantitative measure for alcohol use, was established by Dr Seth's research group at RPA Hospital. This test is now routinely used in clinical settings by Drug Health and Liver clinics to determine alcohol use, changing the management of Alcohol Use Disorder (AUD) patients and used in clinical trials to evaluate alcohol addiction treatment.

Clinical Research in Alcohol, Addictive Behaviours and Treatment

Clinical Research in Alcohol & Addictive behaviours and Treatment is a major area of interest with ongoing randomised control trials, including comorbid substance abuse and suicide risk. The team (led by Associate Professor Kirsten Morley) is leading world first research into alcohol dependence, alcoholic liver disease and their associated psychological comorbidities. The team is currently conducting a number of randomised clinical trials testing novel treatments for alcohol addiction, and how to optimise the response to treatment and improve translation of evidence-based approaches into practice. These include:

Discovery

A study of cannabidiol (CBD) examining the effect of CBD on a range of different functions such as functional connectivity between brain regions, brain activity in response to alcohol and anxiety cues, brain metabolite levels in addition to measures of craving, sleep and mood.
An MRI study comparing the action of topiramate and naltrexone on functional connectivity between brain regions, brain activity in response to alcohol and anxiety cues, brain metabolite levels and the role of genotypes in these actions.
A predictive MRI study examining neural, cognitive and epigenetic predictors of response to MDMA assisted exposure therapy to treat comorbid PTSD and AUD.

Treatment

A randomised, double blind, controlled trial comparing naltrexone to topiramate in the treatment of alcohol dependence. It comprises of a 12-week treatment program with study medications (naltrexone or topiramate) and medical management. NHMRC funded. (2019-2021)
A randomised, double blind, controlled trial investigating whether N-acetylcysteine is a safe and effective treatment for reducing heavy alcohol consumption. In this study participants are randomly allocated to N-acetylcysteine or matched placebo and undergo a 12-week treatment program with study medications (NAC or placebo) and medical management.

Translation

National clinical guidelines for treatment of Alcohol problems. The ECC team led a national working group to revise and update these guidelines and generate implementation tools. (2018-2021)
An evaluation of the effectiveness of the Pathways to Comorbidity Care (PCC) training program in improving the management of comorbid substance use and mental disorders using an integrated comorbidity management approach. Both the clinical practice outcomes and the implementation outcomes were evaluated. Funded by the NSW Health Translational Research Grant Scheme. (2017-2020)
Following on from the PCC project, a need assessment of drug and alcohol and mental health nurses is being conducted to inform a process of engaging leadership in implementing an integrated care management approach to comorbid drug and alcohol and mental disorders with nurses. (2021-2023)

Illicit Drug Use

Selected Grants

Amount awarded	Grant and project details
$3,722,731	NHMRC, 2021 - 2023 Emerging Drugs Network of Australia: a coordinated toxicosurveillance system of illicit drug use in Australia to enable rapid detection and harm reduction responses via an Early Warning System Investigators: Fatovich D, Soderstrom J, Dawson A, Alfred S, Greene S, Isorardi K, Pulbrook L, McCutcheon D, Oosthuize
$3,000,000	NHMRC, 2020 -2025 A Centre of Research Excellence for Integrated Community Care of People with Complex Multi - morbidities Investigators: Eastwood, Hiscock, Goldfield, Gillespie, Haber, de Leeuw, Katz, Page, Schneider, Cunich
$2,614,769	NHMRC, 2021-2025 Better data on methamphetamine s and other drugs among Indigenous Australians to inform policy and practice. Investigators: Lee KSK, Wilson S, Conigrave K, Chikritzhs T, Hayman N, Dawson A, Ali R, Conigrave J, Fitts M
$2,530,928	NHMRC CRE, 2017-2023 A Centre for Research Excellence: Building Indigenous research capacity to find solutions to alcohol problems Investigators: Conigrave K, Wilson S, Shakeshaft A, Hayman N, Haber P, Lee K, Ivers R, Doran C, Clifford A.
$2,500,000	NHMRC, 2020 -2025 NHMRC Centre of Research Excellence in Medicines Intelligence Investigators: Pearson SA, Pratt N, Buckley N, Preen D, Degenhardt L, Van Gool K, Vajdic C, Jorm L, Wilson A, Henry D
$1,329,000	NHMRC/Clinical Trials and Cohort Studies, 2021-2025 A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder Investigators: Baillie A, Morley K, Haber P, Slade T
$798,652	NSW Ministry of Health, 2021-2023 How does longacting depot buprenorphine impact on the high-risk post-release period for people with opioid dependence – The Release Study Investigators: Dunlop, Roberts, Lintzeris, Haber, Ezard, Maher, McEntyre, White, Doyle, Graham
$607,264	NHMRC Investigator Grant, Emerging Leadership 1 , 2022-2026 Alcohol treatment for Aboriginal men in and out of prison Investigators: Doyle M
$557,797	National Healthy and Medical Research Council (Partnership grant) , 2020-2024 A Managed Alcohol Program for Australia Investigators: N Ezard, T Stockwell, K Dolan, E Baldry, C Day, T Dobbins, A Dunlop, A Peacock, J Brett.
$525,000	Australian Research Data Commons, 2021-2023 Boosting public health research with a national poisoning dataset Investigators: Cairns R, Wright N, Elliott R, Wylie C, Lynch AM, Dawson A, Greene S, Isoardi K, Armstrong J, Buckley N, Chiew A, Huynh A, Brown J.
$480,978	NHMRC, 2021-2023 Disentangling the interrelationship between multimordibity, multimedicine use, and cardiovascular health Investigators: Schaffer A, Pearson SA, Buckley NA, Falster M, Brieger D, Abrahamowicz M, Daniels B
$417,500	NHMRC/MRFF Practitioner Fellowship, 2019-2023 Novel treatment for alcohol use disorder Investigators: Haber PS
$196,973	NHMRC, 2019-2023 The eCliPSE Project: implementing evidence-based eHealth interventions for comorbid mental health and alcohol/other drug use problems into health and community settings Investigators: Morley KC (CIG)

Our Publications

2021

Ackermann D, Blyth F, Burgess A, Reid S. Rapid Evidence for Practice modules: using team-based learning to teach evidence-based medicine, International Journal of Epidemiology, Volume 50, Issue Supplement_1, September 2021, dyab168.008, https://doi.org/10.1093/ije/dyab168.008
Al Ansari, M., Dawson, A., & Conigrave, K. (2021). Alcohol: from Mesopotamia to Modern Iraq. J Ethne Subst Abuse, 20(3), 343-365. doi:10.1080/15332640.2019.1657541
Al-AL Ansari, F., et al. (2021). "Health risks, preventive behaviours and respiratory illnesses at the 2019 Arbaeen: Implications for COVID-19 and other pandemics " Environmental Research and Public Health 18(6).
Baillie, A., Marel, C., Mills, K., Morley, K., Teesson, M. (2021). Treatment for comorbidity. Guidelines For The Treatment of Alcohol Problems, Australian Government Department for Health and Aging, Chapter 10. https://alcoholtreatmentguidelines.com.au
Barnett, A., Savic, M., Lintzeris, N., Bathish, R., Arunogiri, S., Dunlop, A. J., . . . Lubman, D. I. (2021). Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia. Drug Alcohol Depend, 227, 108959. doi:10.1016/j.drugalcdep.2021.108959
Best, D., et al. (2021). "Justice Capital: A model for reconciling structural and agentic determinants of desistance." Probation Journal 68(2).
Brett, J., Pearson, S. A., Daniels, B., Wylie, C. E., & Buckley, N. A. (2021). A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. Br J Clin Pharmacol, 87(3), 1369-1377. doi:10.1111/bcp.14527
Bryant, J., et al. (2021). "Beyond deficit: 'strengths-based approaches' in Indigenous health research." Sociology of Health & Fitness.
Buckley, N. A., Fahim, M., Raubenheimer, J., Gawarammana, I. B., Eddleston, M., Roberts, M. S., & Dawson, A. H. (2021). Case fatality of agricultural pesticides after self-poisoning in Sri Lanka: a prospective cohort study. Lancet Glob Health, 9(6), e854-e862. doi:10.1016/s2214-109x(21)00086-3
Chakraborty S, Jones M, Collie A, Kenardy J, Mortimer D, Brijnath B, Enticott J, Kidd M, Trevena L, Reid S, and Mazza D. Implementing work-related Mental health guidelines in general practice (IMPRovE): a protocol for a hybrid-III parallel cluster randomized controlled trial. Implementation Science 2021.16:77
Chan, B. S., & Buckley, N. A. (2021). Authors' reply to comment on: clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. Clin Toxicol (Phila), 1. doi:10.1080/15563650.2021.2013497
Chan, B. S., & Buckley, N. A. (2021). Translating EXTRIP criteria to better define patients with lithium toxicity for haemodialysis. Br J Clin Pharmacol, 87(4), 2157. doi:10.1111/bcp.14567
Chan, B. S., Isbister, G. K., Chiew, A., Isoardi, K., & Buckley, N. A. (2021). Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6). Clin Toxicol (Phila), 1-7. doi:10.1080/15563650.2021.1968422
Chan, B. S., Kiss, A., McIntosh, N., Sheppeard, V., & Dawson, A. H. (2021). E-cigarette or vaping product use-associated lung injury in an adolescent. Med J Aust, 215(7), 313-314.e311. doi:10.5694/mja2.51244
Chiew, A. L., & Buckley, N. A. (2021). Acetaminophen Poisoning. Crit Care Clin, 37(3), 543-561. doi:10.1016/j.ccc.2021.03.005
Chiew, A. L., Buckley, N. A., Graudins, A., & Munir, V. L. (2021). Review article: Up (to) date for Australian Toxicology and Toxinology guidelines. Emerg Med Australas, 33(1), 6-8. doi:10.1111/1742-6723.13663
Chitty, K. M., Schumann, J. L., Moran, L. L., Chong, D. G., Hurzeler, T. P., & Buckley, N. A. (2021). Reporting of alcohol as a contributor to death in Australian national suicide statistics and its relationship to post-mortem alcohol concentrations. Addiction, 116(3), 506-513. doi:10.1111/add.15180
Clapham, K., et al. (2021). "Digital support for Indigenous research methodologies" Australasian Journal of Information Systems 25.
Conigrave, J. H., et al. (2021). "Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities." Addiction Science & Clinical Practise 16(1): 1-11.
Conigrave, J. H., Conigrave, K. M., Wilson, S., & Lee, K. S. K. (2021). Indigenous Australian drinking risk: Comparing risk categorisations based on recall of recent drinking occasions to AUDIT-C screening in a representative sample. Drug Alcohol Rev. doi:10.1111/dar.13403
Conigrave, J. H., Harrison, K. H., Lee, K. S. K., Dobbins, T. A., Hummerston, B., Hayman, N., . . . Conigrave, K. M. (2021). Support can increase use of the AUDIT-C in Australian Aboriginal Community Controlled Health Services: a cluster randomized trial. Addiction, 116(9), 2304-2315. doi:10.1111/add.15428
Conigrave, K. M., Ali, R. L., Armstrong, R., Chikritzhs, T. N., d'Abbs, P., Harris, M. F., . . . Banks, E. (2021). Revision of the Australian guidelines to reduce health risks from drinking alcohol. Med J Aust, 215(11), 518-524. doi:10.5694/mja2.51336
Coupland, H., Day, C., Haber, P., Pritchard-Jones, J., McKee, K., George, J., & McCaughan, G. (2021). Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study. Drug Alcohol Rev. doi:10.1111/dar.13414
Coupland, H., Moensted, M. L., Reid, S., White, B., Eastwood, J., Haber, P., & Day, C. (2021). Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives. J Subst Abuse Treat, 131, 108420. doi:10.1016/j.jsat.2021.108420
Crouse, J. J., Morley, K. C., Buckley, N., Dawson, A., Seth, D., Monds, L. A., Tickell, A., Kay-Lambkin, F., Chitty, K. M. (2021). Online interventions for people hospitalized for deliberate self-harm and problematic alcohol use: Lessons learned from the iiAIM trial. Bull Menninger Clin, 85(2), 123-142. doi:10.1521/bumc.2021.85.2.123
Dale, E., Conigrave, K. M., Kelly, P. J., Ivers, R., Clapham, K., & Lee, K. S. K. (2021). A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia. Addict Sci Clin Pract, 16(1), 2. doi:10.1186/s13722-020-00212-8
Dale, E., Lee, K. S. K., Conigrave, K. M., Conigrave, J. H., Ivers, R., Clapham, K., & Kelly, P. J. (2021). A multi-methods yarn about SMART Recovery: First insights from Australian Aboriginal facilitators and group members. Drug Alcohol Rev, 40(6), 1013-1027. doi:10.1111/dar.13264
Daniels, B., Pearson, S. A., Buckley, N. A., Bruno, C., Schaffer, A., & Zoega, H. (2021). Coming to grips with seemingly conflicting results in programme evaluation: the devil's in the detail. BMJ Qual Saf, 30(1), 70-71. doi:10.1136/bmjqs-2020-012118
Dassanayake, T. L., Weerasinghe, V. S., Gawarammana, I. B., & Buckley, N. A. (2021). Changes of attention-related brain activity over 6 months after acute organophosphate pesticide poisoning: a prospective follow-up study. Clin Toxicol (Phila), 1-9. doi:10.1080/15563650.2021.2010742
Day, C. A., et al. (2021). "Providing appropriate treatment and care to people with alcohol problems: a summary for key specific populations " Medical Journal of Australia 215: S21-S27.
Donald, J. N., et al. (2021). "Paths to the light and dark sides of human nature: A meta-analytic review of prosocial benefits of autonomy and the antisocial costs of control " Psychological Bulletin 147(9): 921-946.
Doyle, M. F. (2021). Alcohol and drug research with Indigenous peoples: where do we go from here? Addiction, 116(3), 435-437. doi:10.1111/add.15176
Doyle, M. F., Williams, M., Butler, T., Shakeshaft, A., Conigrave, K., & Guthrie, J. (2021). Perspectives of prisoners on alcohol and other drug group treatment approaches. Int J Prison Health, ahead-of-print(ahead-of-print). doi:10.1108/ijph-05-2021-0043
Dunlop, A. J., White, B., Roberts, J., Cretikos, M., Attalla, D., Ling, R., ... & Lintzeris, N. (2022). Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction, 117(2), 382-391.
Dzidowska, M., et al. (2021). "Support for Aboriginal health services in reducing harms from alcohol: 2-year service provision outcomes in a cluster randomized trial." Addiction 117(3).
Ediriweera, D. S., Kasthuriratne, A., Pathmeswaran, A., Gunawardene, N. K., Jayamanne, S. F., Murray, K., . . . Diggle, P. J. (2021). Evaluating spatiotemporal dynamics of snakebite in Sri Lanka: Monthly incidence mapping from a national representative survey sample. PLoS Negl Trop Dis, 15(6), e0009447. doi:10.1371/journal.pntd.0009447
Falster, M. O., Charrier, R., Pearson, S. A., Buckley, N. A., & Daniels, B. (2021). Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol, 87(3), 1264-1274. doi:10.1111/bcp.14504
Farhoudian, A., Radfar, S. R., Mohaddes Ardabili, H., Rafei, P., Ebrahimi, M., Khojasteh Zonoozi, A., . . . Ekhtiari, H. (2021). A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Front Psychiatry, 12, 646206. doi:10.3389/fpsyt.2021.646206
Fernando, Kiyara; Jayamanna, Shaluka; Weerasinghe, Manjula; Priyadarshana, Chamil; Ratnayake, Rohan; Pearson, Melissa; Gunnell, David; Dawson, Andrew; Hawton, Keith; Konradsen, Flemming; Risk factors for deliberate self-harm in young people in rural Sri Lanka: a prospective cohort study of 22,000 individuals.
Fitts, M. S., Burchill, R., Wilson, S., Palk, G. R., Clough, A. R., Conigrave, K. M., . . . Lee, K. S. K. (2021). Drink driving among Aboriginal and Torres Strait Islander Australians: What has been done and where to next? Drug Alcohol Rev. doi:10.1111/dar.13418
Forbes MK, Sunderland M, Rapee RM, et al. A Detailed Hierarchical Model of Psychopathology: From Individual Symptoms up to the General Factor of Psychopathology. Clinical Psychological Science. 2021;9(2):139-168. doi:10.1177/2167702620954799
Freeburn, B., et al. (2021). "Coming of age: 21 years of opioid substitution treatment within an Aboriginal community-controlled primary health service." Drug and Alcohol Review.
Giannopoulos, V., Morley, K., Uribe, G., Louie, E., Wood, K., Teesson, M., Baillie, A., Haber, P. (2021). The role of clinical supervision in implementing evidence-based practice for managing comorbidity. The Clinical Supervisor,40(10.158-177
Giannopolous, V., Morley. K, Haber, P (2021). How GPs can help detect and manage alcohol problems during the COVID-19 pandemic? Medicine Today 22 (4): 14-20
Haber, P. S., & Kortt, N. C. (2021). Alcohol use disorder and the gut. Addiction, 116(3), 658-667. doi:10.1111/add.15147
Haber, P. S., Morley, K. C., & Giannopoulos, V. (2021). Alcohol-use and misuse during the COVID-19 pandemic.
Haber, P. S., Riordan, B. C., & Morley, K. C. (2021). Treatment of alcohol problems: current status and future directions. Med J Aust, 215(7), 315-316. doi:10.5694/mja2.51265
Haber, P. S., Riordan, B. C., Winter, D. T., Barrett, L., Saunders, J., Hides, L., ... & Morley, K. C. (2021). New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Medical Journal of Australia, 215, S3-S32.
Haber, P.S., Riordan, B.C., Winter, D.T., Barrett, L., Saunders, J., Hides, L., Gullo, M., Manning, V., Day, C.A., Bonomo, Y. and Burns, L., 2021. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Medical Journal of Australia, 215, pp.S3-S32.
Hamilton, S. L. and S. Maslen (2021). "Redressing 'unwinnable battles': Towards institutional justice capital in Australian child protection." Journal of Sociology: 14407833211010220
Hamilton, S. L., et al. (2021). ""We don't want you to come in and make a decision for us": Traversing cultural authority and responsive regulation in Australian child protection systems." Australian Journal of Social Issues.
L Hides, BC Riordan, M Gullo, KC Morley, V Manning, J Connor, C Quinn. Caring for and managing patients with alcohol problems: interventions, treatments, relapse prevention, aftercare, and long term follow-up. Medical Journal of Australia, 215 (7): S12-S20
Huang, J., Buckley, N. A., Isoardi, K. Z., Chiew, A. L., Isbister, G. K., Cairns, R., . . . Chan, B. S. (2021). Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning. Clin Toxicol (Phila), 59(6), 464-471. doi:10.1080/15563650.2020.1826504
Hurzeler, T., Buckley, N. A., Noghrehchi, F., Malouf, P., Page, A., Schumann, J. L., & Chitty, K. M. (2021). Alcohol-related suicide across Australia: a geospatial analysis. Aust N Z J Public Health, 45(4), 394-399. doi:10.1111/1753-6405.13122
Hurzeler, T., Giannopoulos, V., Uribe, G., Louie, E., Haber, P., & Morley, K. C. (2021). Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials. Alcohol Alcohol, 56(1), 17-27. doi:10.1093/alcalc/agaa094
James, D. B., Lee, K. S. K., Dronavalli, M., Courtney, R. J., Conigrave, K. M., Conigrave, J. H., & Shakeshaft, A. (2021). Predictors of length of treatment, discharge reason, and re-admission to Aboriginal alcohol and other drug residential rehabilitation services in New South Wales, Australia. Drug Alcohol Rev. doi:10.1111/dar.13388
Jiang, E., Raubenheimer, J. E., Isbister, G. K., Chan, B. S. H., & Buckley, N. A. (2021). Machine read frontal QRS-T angle and QTc is no substitute for manual measurement of QTc in pro-arrhythmic drug overdose. J Electrocardiol, 65, 151-156. doi:10.1016/j.jelectrocard.2021.02.006
Jiranantakan, Thanjira; Brown, Jared A; Auld, Robin; Francis, Catherine; Vazquez, Santiago; Shaw, Vanessa; Mcdonald, Catherine; Wright, Nicole E; Dawson, Andrew; Surprise Illicit Substances-Lessons Learned From The Prescription, Recreational And Illicit Substance Evaluation Program In New South Wales. Drug and Alcohol Review. 40S31-S32. 2021
Kloft, L., Monds, L.A., Blokland, A., Ramaekers, J., & Otgaar, H. (2021). Hazy memories in the courtroom: a review of alcohol and other drug effects on false memory and suggestibility. Neuroscience and Biobehavioral Reviews, 124, 291-307
Kaye, S., Lewandowski, A., Bowman, J., & Doyle, M. F. (2021). Crystal methamphetamine use among young people entering custody: Prevalence, correlates and comorbidity. Drug Alcohol Rev, 40(7), 1266-1274. doi:10.1111/dar.13210
Lee, K. K., Conigrave, J. H., Al Ansari, M., Wilson, S., Perry, J., Zheng, C., et al., Conigrave, K. M. (2021). Acceptability and feasibility of a computer-based application to help Aboriginal and Torres Strait Islander Australians describe their alcohol consumption. J Ethn Subst Abuse, 20(1), 16-33. doi:10.1080/15332640.2019.1579144
Lintzeris, N., Dunlop, A. J., Haber, P. S., Lubman, D. I., Graham, R., Hutchinson, S., et al.,Tiberg, F. (2021). Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open, 4(5), e219041. doi:10.1001/jamanetworkopen.2021.9041
Logge WB, Morley KC, Haber PS. GABAB receptors and alcohol use disorders: clinical studies. Behavioral Neurobiology of GABAB Receptor Function. 2021 Feb 13:195-212.
Logge, W. B., Morris, R. W., Baillie, A. J., Haber, P. S., & Morley, K. C. (2021). Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals. Psychopharmacology (Berl), 238(5), 1291-1302. doi:10.1007/s00213-019-05192-5
Louie, E., Barrett, E. L., Baillie, A., Haber, P., & Morley, K. C. (2021). A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework. Implement Sci, 16(1), 22. doi:10.1186/s13012-021-01090-7
Louie, E., Giannopoulos, V., Baillie, A.J., Uribe, G., Wood, K., Teesson, M., Childs, S., Rogers, D., Haber, P.S., & Morley, K.C. (2021). Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings. Frontiers in Health Services.
Louie, E., Morley, K. C., Giannopoulos, V., Uribe, G., Wood, K., Marel, C., et al., Haber, P. S. (2021). Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC). J Dual Diagn, 17(4), 304-312. doi:10.1080/15504263.2021.1984152
Marel, C., Mills, K., Stirling, R., Wilson, J., Haber, P., Teesson, M. (2021). Editorial. Advances in Dual Diagnosis, 14(1), 1-7
Mason, A., Jang, K., Morley, K., Scarf, D., Collings, S. C., & Riordan, B. C. (2021). A Content Analysis of Reddit Users' Perspectives on Reasons for Not Following Through with a Suicide Attempt. Cyberpsychol Behav Soc Netw, 24(10), 642-647. doi:10.1089/cyber.2020.0521
Mazza, D., Chakraborty, S., Camões-Costa, V., Kenardy, J., Brijnath, B., Mortimer, D., et al., Collie, A. (2021). Implementing work-related mental health guidelines in general PRacticE (IMPRovE): a protocol for a hybrid III parallel cluster randomised controlled trial. Implementation Science, 16(1), 77. doi:10.1186/s13012-021-01146-8
M McDonough, AJ Baillie, PJ Clark, L Gowing, LA Stapinski, B Taye, Morley, K.C. Caring for and managing patients with alcohol problems: interventions, treatments, relapse prevention, aftercare, and long term follow-up. Medical Journal of Australia, 215 (7): S28-S32
Moensted ML & Buus N, Day CA. Examining facilitating relational dimensions of service encounters for disadvantaged people who use drugs. Journal of Addictions Nursing. (accepted 04/03/2021)
Moensted ML Day CA. (2021) Operationalising cultural competency in the context of substance use treatment for Australian Muslims: A qualitative analysis. Drugs: Education, Prevention & Policy. doi.org/10.1080/09687637.2021.1872501
Monds, L. A., Riordan, B. C., Flett, J. A. M., Conner, T. S., Haber, P., & Scarf, D. (2021). How intoxicated are you? Investigating self and observer intoxication ratings in relation to blood alcohol concentration. Drug Alcohol Rev, 40(7), 1173-1177. doi:10.1111/dar.13241
Morley, K. C. (2021). Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact. Addiction, 116(11), 3027-3028. doi:10.1111/add.15532
Morley, K. C., Logge, W. B., Fraser, I., Morris, R. W., Baillie, A. J., & Haber, P. S. (2021). High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study. Eur Neuropsychopharmacol, 46, 28-36. doi:10.1016/j.euroneuro.2021.02.010
Morley, K. C., Logge, W. B., Riordan, B. C., Brannon, S., Haber, P. S., & Conner, T. S. (2021). Daily experiences of hangover severity and food consumption in young adults. Br J Health Psychol. doi:10.1111/bjhp.12555
Morley, K. C., Perry, C. J., Watt, J., Hurzeler, T., Leggio, L., Lawrence, A. J., & Haber, P. (2021). New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies. Expert Opin Pharmacother, 22(10), 1291-1303. doi:10.1080/14656566.2021.1892641
Morley, K.C. Rombouts, S. Jamshidi, N., Haber, P.S. (2021). Pharmacotherapies for alcohol dependence. Guidelines For The Treatment of Alcohol Problems, Australian Government Department for Health, Chapter 7. https://alcoholtreatmentguidelines.com.au/
Nielsen, S., Sanfilippo, P., Belackova, V., Day, C., Silins, E., Lintzeris, N.,et al., Larance, B. (2021). Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction, 116(6), 1482-1494. doi:10.1111/add.15297
Noroozi, A., et al. (2021). "Factors influencing engagement and utilisation of opium tincture-assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran " Drug and Alcohol Review 41(2).
O'Neill, C., Najjar, Z., Ingleton, A., Edwards, A., Dawson, A., & Gupta, L. (2021). Methaemoglobinaemia associated with the atypical use of sodium nitrite as a food additive. Med J Aust, 215(6), 256-257.e251. doi:10.5694/mja2.51233
Osna, N. A., Ganesan, M., Seth, D., Wyatt, T. A., Kidambi, S., & Kharbanda, K. K. (2021). Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol, 56(1), 8-16. doi:10.1093/alcalc/agaa085
Perananthan, V., Mohamed, F., Shahmy, S., Gawarammana, I., Dawson, A., & Buckley, N. (2021). The clinical toxicity of imidacloprid self-poisoning following the introduction of newer formulations. Clin Toxicol (Phila), 59(4), 347-350. doi:10.1080/15563650.2020.1815760
Perananthan, V., Tremonti, C., Nash, E., Jiranantakan, T., & Dawson, A. H. (2021). Rapid detection, toxicosurveillance and public health response to stimulant adulteration with acetyl fentanyl. Med J Aust, 214(11), 533-533.e531. doi:10.5694/mja2.51112
Prasadi, GAM; Senarathna, L; Dharmaratne, SD; Mohamed, F; Jayasinghe, SS; Dawson, A; Mothers' ability to determine and measure paracetamol doses for children-a contrived observational study. Journal of Child Health Care 1.36749E+16 2021
Prior, K., Salemink, E., Wiers, R. W., Teachman, B. A., Piggott, M., Newton, N. C.,et al., Stapinski, L. A. (2021). A Web-Based Cognitive Bias Modification Intervention (Re-train Your Brain) for Emerging Adults With Co-occurring Social Anxiety and Hazardous Alcohol Use: Protocol for a Multiarm Randomized Controlled Pilot Trial. 10(7), e28667. doi:10.2196/28667
Pushpakumara, P., Dawson, A., Adikari, A., Thennakoon, S., Abeysinghe, R., Rajapakse, T. (2021). Exploration of associations between deliberate self-poisoning and psychiatric disorders in rural Sri Lanka: A case-control study. PloS one,16(8), e0255805
Radfar, S. R., De Jong, C. A. J., Farhoudian, A., Ebrahimi, M., Rafei, P., Vahidi, M., et al., Baldacchino, A. M. (2021). Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry, 12, 639393. doi:10.3389/fpsyt.2021.639393
Raubenheimer, J. E., Riordan, B. C., Merrill, J. E., Winter, T., Ward, R. M., Scarf, D., & Buckley, N. A. (2021). Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum. Int J Drug Policy, 90, 103083. doi:10.1016/j.drugpo.2020.103083
Riordan, B. C., Winter, D. T., Haber, P. S., Day, C. A., & Morley, K. C. (2021). What are people saying on social networking sites about the Australian alcohol consumption guidelines? Med J Aust, 214(3), 105-107.e101. doi:10.5694/mja2.50902
Roberts, D. M., Hughes, H. K., Haber, P. S., & Jones, G. R. (2021). Variability in insulin pharmacokinetics following high-dose insulin therapy. Clinical Toxicology, 1-3.
Roberts, J., White, B., Attalla, D., Ward, S., & Dunlop, A. J. (2021). Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia. Addiction, 116(2), 426-427. doi:10.1111/add.15244
Roxburgh, A., Jauncey, M., Day, C., Bartlett, M., Cogger, S., Dietze, P.,et al., Clark, N. (2021). Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Harm Reduct J, 18(1), 20. doi:10.1186/s12954-021-00471-x
Schaffer, A. L., Brett, J., Buckley, N. A., & Pearson, S. A. (2021). Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use. Pain. doi:10.1097/j.pain.0000000000002433
Schwantes-An, T. H., Darlay, R., Mathurin, P., Masson, S., Liangpunsakul, S., Mueller, S., et al., Seth, D. (2021). Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology, 73(5), 1920-1931. doi:10.1002/hep.31535
Seifert, S. A., Buckley, N., Chan, B., Chan, T. Y. K., Cumpston, K., Kirschner, R. I., et al., Wilks, M. F. (2021). Clinical Toxicology review metrics and expert reviewers, 2020. Clin Toxicol (Phila), 59(3), e1-e3. doi:10.1080/15563650.2021.1874197
Shihana, F., Barron, M. L., Mohamed, F., Seth, D., & Buckley, N. A. (2021). MicroRNAs in toxic acute kidney injury: Systematic scoping review of the current status. Pharmacol Res Perspect, 9(2), e00695. doi:10.1002/prp2.695
Shihana, F., Wong, W. K. M., Joglekar, M. V., Mohamed, F., Gawarammana, I. B., Isbister, G. K., Hardikar AA, Seth D, Buckley, N. A. (2021). Urinary microRNAs as non-invasive biomarkers for toxic acute kidney injury in humans. Sci Rep, 11(1), 9165. doi:10.1038/s41598-021-87918-0
Siefried, K. J., Ezard, N., Christmass, M., Haber, P., Ali, R., & NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group. (2022). A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia. Drug and Alcohol Review, 41(2), 309-319.
Snijder, M., et al. (2021). "Strong and Deadly Futures: Co-Development of a Web-Based Wellbeing and Substance Use Prevention Program for Aboriginal and Torres Strait Islander and Non-Aboriginal Adolescents." International journal of environmental research and public health 18(4): 2176.
Stapinski, L. A., Sannibale, C., Subotic, M., Rapee, R. M., Teesson, M., Haber, P. S., & Baillie, A. J. (2021). Randomised controlled trial of integrated cognitive behavioural treatment and motivational enhancement for comorbid social anxiety and alcohol use disorders. Aust N Z J Psychiatry, 55(2), 207-220. doi:10.1177/0004867420952539
Stearne, A. E., et al. (2021). "Identifying how the principles of self-determination could be applied to create effective alcohol policy for First Nations Australians: Synthesising the lessons from the development of general public policy." International Journal of Drug Policy: 103260.
Subotic-Kerry, M., Baillie, A., Stapinski, L., Abbott, M., MacDonald, J., Gaston, J., Rapee, R. (2021). The impact of alcohol use disorders and alcohol consumption on treatment-seeking individuals with social anxiety disorder. Bulletin of the Menninger Clinic, 85(2), 100-122.
Sullivan, A., Ridley, N., Monds, L. A., Logge, W., Hurzeler, T., & Morley, K. (2021). Neuropsychological profiles on the Weschler Adult Intelligence Scale (WAIS-IV) of individuals attending a long-term residential rehabilitation program for substance use problems. Applied Neuropsychology: Adult; and Preprinted in PsyArXiv. https://doi.org/10.31234/osf.io/87rd5
Sunderland, M., Forbes, M., Mewton, L., Baillie, A., Carragher, N., Lynch, S., Batterham, P., Calear, A., Chapman, C., Newton, N., Teesson, M., Slade, T. (2021). The structure of psychopathology and association with poor sleep, self-harm, suicidality, risky sexual behavior, and low self-esteem in a population sample of adolescents. Development and Psychopathology, 33(4), 1208-1219.
Suntai, Z., & White, B. (2021). Social isolation among older veterans: findings from the National Health and Aging Trends Study. Aging Ment Health, 1-8. doi:10.1080/13607863.2021.1942434
Tong, A., Sorrell, T., Black, A., Caillaud, C., Chrzanowski, W., Li, E., Martinez-Martin, D., McEwan, A., Wang, R., Motion, A., Casas Bedoya, A., Huang, J., Azizi, L., Eggleton, B., Andersen, T., Baillie, A., Barratt, A., Boehm, C., Britton, P., Chadban, S., Chow, C., Fleming, S., Fox, G., Gordon, L., Ho-Baillie, A., Howell, M., Hickie, I., Hunt, N., Iredell, J., Jin, C., Kairaitis, K., Kavehei, O., Kritharides, L., Leon-Saval, S., Lindley, R., Maguire, S., McCluskey, M., McKay, N., Mifsud, G., Palomba, S., Pettigrew, A., Postnova, S., Prinable, J., Rabeau, J., Rees, M., Richmond, K., Scholes Robertson, N., Seppelt, I., Shaw, T., Sintchenko, V., Snelling, T., Teixeira-Pinto, A., Tovey, E., Tuniz, A., Varamini, P., Wang, A., Wang, K., Wise, S., Zoellner, H., et al (2021). Research priorities for COVID-19 sensor technology. Nature Biotechnology, 39(2), 144-153
Tran, V., Reid, S. E., Roxburgh, A., & Day, C. A. (2021). Assessing Drug Consumption Rooms and Longer Term (5 Year) Impacts on Community and Clients. Risk Manag Healthc Policy, 14, 4639-4647. doi:10.2147/rmhp.S244720
Vichitkunakorn, P., Conigrave, K. M., Geater, A. F., & Assanangkornchai, S. (2021). A Context-Specific Instrument to Record Drinking Behaviour: A Pilot Study on Implications of Identifying the Context of Risky Drinking. Community Ment Health J, 57(1), 167-177. doi:10.1007/s10597-020-00629-0
Watt J, Haber P, Conigrave K. Managing unhealthy alcohol use in general practice. Australian Doctor. 2022;4 March 2022:13-20
Weatherall, T. J., et al. (2021). "Prevalence and correlates of alcohol dependence in an Australian Aboriginal and Torres Strait Islander representative sample: Using the Grog Survey App." Drug and Alcohol Review.
Weatherall, T. J., et al. (2021). "Alcohol dependence in a community sample of Aboriginal and Torres Strait Islander Australians: harms, getting help and awareness of local treatments." Addiction Science & Clinical Practise 16(1): 1-11.
Whitfield, J. B., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G. P., Eyer, F.,et al., Seth, D. (2021). Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. Am J Gastroenterol, 116(1), 106-115. doi:10.14309/ajg.0000000000000833
Whitfield, J. B., Schwantes-An, T. H., Darlay, R., Aithal, G. P., Atkinson, S. R., Bataller, R.,et al., & GenomALC Consortium. (2022). A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. Journal of hepatology, 76(2), 275-282.
Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14. Erratum in: J Hepatol. 2022 Mar 11;: PMID: 34656649; PMCID: PMC8803006.
Wijewickrama, E. S., Mohamed, F., Gawarammana, I. B., Endre, Z. H., Buckley, N. A., & Isbister, G. K. (2021). Serum and urinary biomarkers for early detection of acute kidney injury following Hypnale spp. envenoming. PLoS Negl Trop Dis, 15(12), e0010011. doi:10.1371/journal.pntd.0010011
Winter, D. T., Geiger, B., Morley, K., Conigrave, J., Haber, P. S., & Riordan, B. C. (2021). Are bottle shops using Twitter to increase advertising or encourage drinking during COVID-19? Aust N Z J Public Health, 45(4), 391-393. doi:10.1111/1753-6405.13118
Winter, D. T., White, N., Geiger, B., Haber, P. S., & Day, C. A. (2021). Should we be using e-vouchers to compensate research participants? Acceptability among opioid agonist treatment clients. Drug Alcohol Rev, 40(7), 1356-1357. doi:10.1111/dar.13287
Zheng, C., et al. (2021). "Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self?reported on the Grog Survey App: A representative urban and remote sample." Drug and Alcohol Review.

2020

Adams, C., Conigrave, J., Lewohl, J., Haber, P., Morley, K. (2020). Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 89, 501-512. ISSN 0889-1591, https://doi.org/10.1016/j.bbi.2020.08.002.

Al-Ansari, B., Noroozi, A., Thow, A., Day, C., Mirzaie, M., Conigrave, K. (2020). Alcohol treatment systems in Muslim majority countries: Case study of alcohol treatment policy in Iran. International Journal of Drug Policy, 80, 102753. https://doi.org/10.1016/j.drugpo.2020.102753

Albuquerque PLMM, Paiva JHHGL, Martins AMC, Meneses GC, da Silva GB, Buckley N, Daher EF. (2020) Clinical assessment and pathophysiology of Bothrops venom-related acute kidney injury: a scoping review. J Venom Anim Toxins Incl Trop Dis ;26:e20190076. doi: 10.1590/1678-9199-JVATITD-2019-0076. PMID: 32704246; PMCID: PMC7359628.

Athavale A, Jamshidi N, Roberts DM. (2020) Anticipating an incomplete response to the recommended dose of idarucizumab. Clinical Toxicology, 58:6, 505-652

Athavale A, Jamshidi N, Roberts DM (2020) Quantifying the impact of acute and chronic kidney dysfunction on the effect of idarucizumab. Nephrology 25, Suppl. 3; 40 - 82

Athavale A, Jamshidi N, Roberts DM (2020). Use for laboratory tests for identifying patients at risk of an incomplete response to the recommended dose of idarucizumab. Clinical Toxicology, 58:6, 505-652

Bajis, S., Grebely, J., Hajarizadeh, B., Applegate, T., Marshall, A., Ellen Harrod, M., Byrne, J., Bath, N., Edwards, M., Gorton, C., Haber, P., et al (2020). Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study. Journal of Viral Hepatitis, 27(3), 281-293. https://doi.org/10.1111/jvh.13233

Belackova V, Salmon AM, Jauncey M, Day CA. Safer injecting facilities-is the research there? A comment on Caulkins et al. (2020). Addiction. 2020 Apr;115(4):784-785. doi: 10.1111/add.14885. Epub 2019 Dec 29. PMID: 31692143

Black, E., Govindasamy, L., Auld, R., McArdle, K., Sharpe, C., Dawson, A., Vazquez, S., Brett, J., Friend, C., Shaw, V., et al (2020). Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case series. Drug and Alcohol Dependence, 213, 108070. https://doi.org/10.1016/j.drugalcdep.2020.108070

Bravo, M., Monds, L.A., Mills, L., Read, P., Harrod, M.E., Nielsen, S., Jauncey, M., Rivas, C., Malcolm, A., & Lintzeris, N. (2020). The role of repeat training in participants undertaking take home naloxone interventions. Preprinted in medRxiv.https://doi.org/10.1101/2020.04.26.20074542

Brett, J, Pearson, S‐A, Daniels, B, Wylie, CE, Buckley, NA. (2020) A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. Br J Clin Pharmacol. 1- 10. https://doi.org/10.1111/bcp.14527

Brown J., Berling I., Jiranantakan T., Buckley N., Dawson A. (2020) "Changing pattersn in deliberate self-poisonings from internet promotion: sodium nitrate". Clinical Toxicology 58(11) 1104-1105

Brown J., Buckley N., Cairns R., Wylie CE., (2020) Recognising injuries related to needlestick injury in farmers: the importance of identifying high pressure injections with mineral oil. The Medical Journal of Australia 212(2) 94 e1.

Bruno, C., Pearson, S., Daniels, B., Buckley, N., Schaffer, A., Zoega, H. (2020). Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia. BMJ Quality and Safety, 29(5), 365-373.

Cairns R., Buckley N. (2020) After the deluge. The Australian Journal of Pharmacy 101 (1193) 34.

Chan, B., Cheng, S., Isoardi, K., Chiew, A., Siu, W., Shulruf, B., Vecellio, E., Buckley, N. (2020). Effect of age on the severity of chronic lithium poisoning. Clinical Toxicology, 58(11), 1023-1027. https://doi.org/10.1080/15563650.2020.1726376

Chan, B.S. and Buckley, N.A. (2021), Translating EXTRIP criteria to better define patients with lithium toxicity for haemodialysis. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14567

Cheng, S., Buckley, N., Siu, W., Chiew, M., Vecellio, E., Chan, B. (2020). Seasonal and temperature effect on serum lithium concentrations. Australian and New Zealand Journal of Psychiatry, 54(3), 282-287. https://doi.org/10.1177/0004867419889160

Chiew, A., Reith, D., Pomerleau, A., Wong, A., Isoardi, K., Soderstrom, N., Buckley, N. (2020). Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Medical Journal of Australia, 212(4), 175-183. https://doi.org/10.5694/mja2.50428

Chiew, A.L., Buckley, N.A., Graudins, A. and Munir, V.L. (2021), Review article: Up (to) date for Australian Toxicology and Toxinology guidelines. Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.13663

Chitty, K. M., Schumann, J. L., Moran, L. L., Chong, D. G., Hurzeler, T. P., and Buckley, N. A. (2020) Reporting of alcohol as a contributor to death in Australian national suicide statistics and its relationship to post‐mortem alcohol concentrations. Addiction, https://doi.org/10.1111/add.15180.

Chitty, K., Schumann, J., Schaffer, A., Cairns, R., Gonzaga, N., Raubenheimer, J., Carter, G., Page, A., Pearson, S., Buckley, N. (2020). Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study. BMJ Open, 10(5), e038181. doi: 10.1136/bmjopen-2020-038181

Chong, D., Buckley, N., Schumann, J., Chitty, K. (2020). Acute alcohol use in Australian coronial suicide cases, 2010-2015. Drug and Alcohol Dependence, 212, 108066. https://doi.org/10.1016/j.drugalcdep.2020.108066

Chung, P., Logge, W. B., Riordan, B.C., Haber, P. S., Merriman, M. E., Phipps-Green, A., Topless, R., Merriman, T., Conner, T. S., Morley, K. (2020). Genetic polymorphisms on OPRM1, DRD2, DRD4 and COMT in emerging adults: lack of association with alcohol consumption. Frontiers in Psychiatry, 11, 1429.

Conigrave JH, Harrison KH, Lee KSK, Dobbins T, Hummerston B, Hayman N, Perry J, Ivers R, Haber PS, Wilson S, Johnson D, Conigrave KM. (2021) Support can increase use of the AUDIT-C in Australian Aboriginal Community Controlled Health Services: a cluster randomised trial. Addiction. doi: 10.1111/add.15428. Online ahead of print. PMID: 33565676"

Coupland H, Moensted ML, Reid S, White B, Eastwood J, Haber P & Day CA (2021). Developing a model of care for Substance Use in Pregnancy and Parenting Services, Sydney, Australia: Service provider perspectives. Journal of Substance Abuse Treatment (accepted)

Crouse, J.J., Morley, K.C., Buckley, N., Dawson, A., Seth, D., Monds, L.A., Tickell, A., Kay-Lambkin, F., & Chitty, K.M. (2021). Online interventions for people hospitalized for deliberate self-harm and problematic alcohol use: Lessons learned from the iiAIM trial. Bulletin of the Menninger Clinic.

Cullen, H., & Monds, L.A. (2020) Jury simulation studies: To exclude or not to exclude participants based on a lack of comprehension of the case? Applied Cognitive Psychology.

Dale, E., Conigrave, K.M., Kelly, P.J., Ivers R., Clapham K., Lee K.S. (2021) A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia. Addict Sci Clin Pract 16, 2. https://doi.org/10.1186/s13722-020-00212-8

Daniels B, Pearson S, Buckley NA, et al. (2021) Coming to grips with seemingly conflicting results in programme evaluation: the devil's in the detail. BMJ Quality & Safety;30:70-71.

Daniels, B, Pearson, S-A, Vajdic, CM, Pottegård, A, Buckley, NA, Zoega, H. (2020) Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study. Basic Clin Pharmacol Toxicol; 127: 320- 328. https://doi.org/10.1111/bcpt.13463

Daniels, B., Pearson, S., Buckley, N., Bruno, C., Zoega, H. (2020). Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016. Therapeutic Advances in Gastroenterology, 13, 1-11. https://doi.org/10.1177/1756284820913743

Dassanayake TL, Weerasinghe VS, Gawarammana I, Buckley NA. (2020) Subacute and chronic neuropsychological sequalae of acute organophosphate pesticide self-poisoning: a prospective cohort study from Sri Lanka. Clin Toxicol (Phila):1-13. doi: 10.1080/15563650.2020.1778719. Epub ahead of print. PMID: 32567959.

Day, C., White, B., Reid, S., Fowler, M., Black, K. (2020). Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study. Australian and New Zealand Journal of Public Health, 44(5), 360-362. https://doi.org/10.1111/1753-6405.13025

Day, C., White, N. (2020). Gender-Specific Online Content Is Important and Timely for Women Receiving Treatment for Substance Use Disorders. Journal of Women's Health, 29(5), 605-606. https://doi.org/10.1089/jwh.2020.8496

De Silva L. Dawson AH., Tennakoon S., Gawarammana IB., J Kider...(2020) Life After non-fatal self-poisoning: a qualitative study on relationships and life circumstances after non-fatal self-poisoning. Clinical Toxicology 58(4) 305

Downs J., Lotan M., Elefant C., Leonard H., Wong K., Buckley N., Stahlhut M. (2020) Protocol: Implementing telehealth support to increase physical activity in girls and women with Rett syndrome-ActivRett: protocol for a waitlist randomised controlled trial. BMJ Open 10 (12).

Doyle, M. F. (2020) Alcohol and drug research with Indigenous peoples: where do we go from here?. Addiction, https://doi.org/10.1111/add.15176.

Doyle, M., Guthrie, J., Butler, T., Shakeshaft, A., Conigrave, K., Williams, M. (2020). Onset and trajectory of alcohol and other drug use among Aboriginal men entering a prison treatment program: A qualitative study. Drug and Alcohol Review, 39(6), 704-712. https://doi.org/10.1111/dar.13123

Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G., Ryan, J., Hall, M., Ezard, N., Haber, P., Lintzeris, N., et al (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(1), 26. https://doi.org/10.1186/s12954-020-00370-7

Eastwood, J., Barmaky, S., Hansen, S., Miller, E., Ratcliff, S., Fotheringham, P., Coupland, H. and De Souza, D., (2020). Refining Program Theory for a Place-Based Integrated Care Initiative in Sydney, Australia. International Journal of Integrated Care, 20(3), p.13. DOI: http://doi.org/10.5334/ijic.5422

Eastwood, J.G., Dewhurst, S., Hansen, S., Tennant, E., Miller, E., Moensted, M.L., Fotheringham, P. and De Souza, D., (2020). Care Coordination for Vulnerable Families in the Sydney Local Health District: What Works for Whom, under What Circumstances, and Why?. International Journal of Integrated Care, 20(4), p.22. DOI: http://doi.org/10.5334/ijic.5437

Egunsola O., Buckley N., Raubenheimer JE., (2020) Price mark-up on the street sales of prescription pharmaceuticals in Australia. Journal of Substance Use, 1-8.

Falster, MO, Charrier, R, Pearson, S‐A, Buckley, NA, Daniels, B. (2020) Long‐term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol; 1- 11. https://doi.org/10.1111/bcp.14504

Fisher, A., Marel, C., Morley, K., Teesson, M., and Mills, K., (2020). "The roleof alcohol and other drugs in suicidal behaviour and effective interventions to reduce suicidal thoughts and behaviours". Evidence check prepared for the National Suicide Prevention Task Force and commissioned through the Suicide Prevention Research Fund, managed by Suicide Prevention Australia.

Flett JAM, Conner TS, Riordan BC, Patterson T, Hayne H. (2020) App-based mindfulness meditation for psychological distress and adjustment to college in incoming university students: a pragmatic, randomised, waitlist-controlled trial. Psychol Health. 35(9):1049-1074. doi: 10.1080/08870446.2019.1711089. Epub 2020 Feb 12. PMID: 32046499.

Giannopoulos, V., Morley, K., Uribe , M.G., Louie, E., Wood, K., Teesson, M., Baillie, A., & Haber, P. (2021). The role of clinical supervision in implementing evidence-based practise for managing comorbidity. The Clinical Supervisor, Special Issue on Clinical Supervision Research in Implementation Science, July 2021 in press.

Graham, S., Mason, A., Riordan, B. C., Winter, T., & Scarf, D. (2021). Does taking a break from social media improve wellbeing? Cyberpsychology, Behavior, and Social Networking

Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., Olver, I., Walsh, A., McGregor, I., Cheung, Y., Simes, R., Stockler, M., et al (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology, 31(11), 1553-1560. https://doi.org/10.1016/j.annonc.2020.07.020

Haber PS, Kortt NC. (2021) Alcohol use disorder and the gut. Addiction. 116(3):658-667. doi: 10.1111/add.15147. Epub 2020 Jul 7. PMID: 32511812

Haghighi-Morad M, Naseri Z, Jamshidi N, Hassanian-Moghaddam H, Zamani N, Ahmad-Molaei L. (2020) Methadone-induced encephalopathy: a case series and literature review. BMC Med Imaging. 20(1):6. doi: 10.1186/s12880-020-0410-9. PMID: 31952488; PMCID: PMC6969410.

Hamilton, S., Maslen, S., Watkins, R., Conigrave, K., Freeman, J., O'Donnell, M., Mutch, R., Bower, C. (2020). "That thing in his head": Aboriginal and non-Aboriginal Australian caregiver responses to neurodevelopmental disability diagnoses. Sociology of Health & Illness, 42(7), 1581-1596. https://doi.org/10.1111/1467-9566.13146

Huang J, Buckley NA, Isoardi KZ, Chiew AL, Isbister GK, Cairns R, Brown JA, Chan BS. (2020) Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning. Clin Toxicol (Phila). 1-8. doi: 10.1080/15563650.2020.1826504. Epub ahead of print. PMID: 33021397.

Hurzeler, T., Giannopoulos, V., Guajardo, M., Louie, E., Haber, P.S., & Morley, K. (2020) Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials. Alcohol & Alcoholism. DOI: 10.1093/alcalc/agaa094

Isbister GK. Buckley N. (2020) "Risks and realities of single vial antivenom recommendations for envenoming by Australian elapid snakes". The Medical Journal of Australia 213(1): 45 e1

Isoardi, K., Mudge, D., Harris, K., Dimeski, G., Buckley, N. (2020). Methamphetamine intoxication and acute kidney injury: A prospective observational case series. Nephrology, 25(10), 758-764. https://doi.org/10.1111/nep.13762

James, D., Lee, K., Patrao, T., Courtney, R., Conigrave, K., Shakeshaft, A. (2020). Understanding the client characteristics of Aboriginal residential alcohol and other drug rehabilitation services in New South Wales, Australia. Addiction Science & Clinical Practice, 15(1), 27. https://doi.org/10.1186/s13722-020-00193-8

Jamshidi, N., Athavale, A., Murnion B. (2020) Buprenorphine not detected on routine urine drug screening in supervised treatment. Journal of Opioid management (Accepted) October 2020

Jamshidi, N., Clark D., Murnion B. (2021) Recurrent Takotsubo cardiomyopathy associated with opioid withdrawal during Buprenorphine induction. Cardiovascualr toxicology Cardiovasc Toxicol. doi: 10.1007/s12012-020-09624-z

Jiang E., Raubenheimer JE., Ibister GK., Chan BSH, Buckley N. (2021) "Machine read frontal QRS-T angle and QTc is no substitute for manual measurement of PTc in pro-arrhythmic drug overdose". Journal of Electrocardiology vol 65: 151-156

Kaye, S., Lewandowski, A., Bowman, J. and Doyle, M.F. (2021), Crystal methamphetamine use among young people entering custody: Prevalence, correlates and comorbidity. Drug Alcohol Rev.. https://doi.org/10.1111/dar.13210

Kirpich, I., Warner, D., Feng, W., Joshi-Barve, S., McClain, C., Seth, D., Zhong, W., Zhou, Z., Osna, N., Kharbanda, K. (2020). Mechanisms, Biomarkers and Targets for Therapy in Alcohol-associated Liver Injury: From Genetics to Nutrition: Summary of the ISBRA 2018 Symposium. Alcohol, 83, 105-114. https://doi.org/10.1016/j.alcohol.2019.05.004

Kloft, L., Monds, L. A., Blokland, A., Ramaekers, J. G., & Otgaar, H. (2021). Hazy memories in the courtroom: a review of alcohol and other drug effects on false memory and suggestibility. Neuroscience & Biobehavioral Reviews.

Kloft, L., Otgaar, H., Blokland, A., Monds, L.A., Toennes, S.W., Loftus, E.F., & Ramaekers, J.G. (2020). Cannabis Increases Susceptibility to False Memory. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 117(9), 4585-4589

Lee, K., Fitts, M., Conigrave, J., Zheng, C., Perry, J., Wilson, S., Chee, D., Bond, S., Slade, T., Conigrave, K., et al (2020). Recruiting a representative sample of urban South Australian Aboriginal adults for a survey on alcohol consumption. BMC Medical Research Methodology, 20(1), 183.https://doi.org/10.1186/s12874-020-01067-y

Lees B., Squeglia L., McTeague L., Forbes M., Krueger R., Sunderland M., Baillie A, Koch F, Teesson M, Mewton L. (2020) Altered Neurocognitive Functional Connectivity and Activation Patterns Underlie Psychopathology in Preadolescence,Biological Psychiatry: Cognitive Neuroscience and Neuroimaging,2020,ISSN 2451-9022,https://doi.org/10.1016/j.bpsc.2020.09.007.

Lees, B., Stapinski, L., Prior, K., Sunderland, M., Newton, N., Baillie, A., Teesson, M., Mewton, L. (2020). Exploring the complex inter-relations between internalising symptoms, executive functioning and alcohol use in young adults. Addictive Behaviors, 106, 106351. https://doi.org/10.1016/j.addbeh.2020.106351

Lintzeris, N., Monds, L., Bravo, M., Read, P., Harrod, M., Wood, W., Nielsen, S., Dietze, P., Lenton, S., Shanahan, M., Haber, P., et al (2020). Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives. Drug and Alcohol Review, 39(1), 55-65. https://doi.org/10.1111/dar.13015

Liu K., Verset G., Trepo E., Seth D. (2020) Genetics of alcohol-related hepatocellular carcinoma- its role in risk prediction. Hepatoma Research. DOI: 10.20517/2394-5079.2020.25

Louie, E., Barrett. E., Haber, P., Baillie, A., Morley, K (senior) (2021). A systematic review of evidence-based practice implementation in drug and alcohol settings: Applying the Consolidated Framework for Implementation Research Framework, Implementation Science, 16:22

Ly J, Brown JA, Buckley NA, et al (2020) Paediatric poisoning exposures in schools: reports to Australia's largest poisons centre. Archives of Disease in Childhood Published Online First. doi: 10.1136/archdischild-2020-319919

Marel C, Mills K, Visontay R, Wilson J, Darke S, Ross J, Slade T, Haber P, Haasnoot K, Keavent M, Tremonti C, Teesson M. (2020) Australian treatment outcome study: protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use. BMJ Open. 2020;10(7):e039226. Published 2020 Jul 12. doi:10.1136/bmjopen-2020-039226

Mason, A., Jang, K., Morely, K., Scarf, D., & Riordan, B. C*. (2021). A content analysis of Reddit users' reasons for not following through with a suicide attempt. Cyberpsychology, Behavior, and Social Networking.

Moensted ML (2020) Nearness and distance: the double-sided nature of belonging for young refugees in Australia, Social Identities, 26:2, 270-285, DOI: 10.1080/13504630.2020.1761316

Moensted ML., Day CA. (2021) Operationalising cultural competency in the context of substance use treatment for Australian Muslims: A qualitative analysis. Drugs: Education, Prevention & Policy. DOI: 10.1080/09687637.2021.1872501

Moensted ML. (2020) Social Citizenship Aspirations: An Alternative Line of Analysis of the Social Reproduction of Youth Inequality. YOUNG. doi:10.1177/1103308820966437

Moensted, M., Day, C. (2020). Health and social interventions in the context of support and control: The experiences of marginalised people who use drugs in Australia. Health and Social Care in the Community, 28(4), 1152-1159. https://doi.org/10.1111/hsc.12946 

Moensted, M.L. (2020) Examining Aspirational Horizons: Desirable and Achievable Futures for Disadvantaged Young People. JAYS 3, 65-78. https://doi.org/10.1007/s43151-020-00008-2

Moensted, M.L., Day, C.A. & Buus, N. (2020) Youth Practitioners' Perspectives on Building Agency and Supporting Transitions with and for Young People Experiencing Disadvantage. JAYS 3, 293-310. https://doi.org/10.1007/s43151-020-00026-0

Monds, L. A., Cullen, H. J., Kloft, L., Sumampouw, N. E. J., van Golde, C., Harrison, A., & Otgaar, H. (2020). Police perceptions of eyewitness impairment due to alcohol and other drug use: a cross-cultural comparison. Preprinted in PsyArXiv. https://doi.org/10.31234/osf.io/c2htb

Monds, L. A., Cullen, H. J., Kloft, L., van Golde, C., Harrison, A., & Flowe, H. D. (2020). Memory and Credibility Perceptions of Alcohol and Other Drug Intoxicated Witnesses and Victims of Crime. Preprinted in PsyArXiv. https://doi.org/10.31234/osf.io/3afvq

Monds, L.A., Riordan, B., Flett, J., Conner, T.S., Haber, P., & Scarf, D. (2021). How intoxicated are you? Investigating self and observer intoxication ratings in relation to BAC. Drug and Alcohol Reivew; and Preprinted in PsyArXiv.https://doi.org/10.31234/osf.io/n8xrb

Morley, K., Lagopoulos, J., Logge, W., Baillie, A., Adams, C., Haber, P. (2020). Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study. Addiction Biology, 25(1), e12702. https://doi.org/10.1111/adb.12702

Morley, K., Perry, C., Watts, J., Hurzeler, T., Leggio, L., Lawrence, A., Haber, P. (2021) New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies. Expert Opinion in Pharmacotherapy. DOI: 10.1080/14656566.2021.1892641

Morley, K.C., Morris, R., Logge, W., Baillie, A., Fraser, I., Haber, P., (2021) High dose baclofen administration attenuates insula response during anticipatory anxiety in alcohol dependent patients: preliminary results. European J neuropsych, accepted with revisions

Nielsen S, Sanfilippo P, Belackova V, Day C, Silins E, Lintzeris N, Bruno R, Grebely J, Lancaster K, Ali R, Bell J, Dietze P, Degenhardt L, Farrell M, Larance B. (2020) Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction. doi: 10.1111/add.15297. Online ahead of print. PMID: 33067836 "

Oluwaseun Egunsola, Nicholas A. Buckley & Jacques E. Raubenheimer (2020) Price mark-up on the street sales of prescription pharmaceuticals in Australia, Journal of Substance Use, DOI: 10.1080/14659891.2020.1851405

Osna N, Ganesan M, Seth D, Wyatt T., Kidambi S, Kharbanda K. (2021) Second hits exacerbate alcohol-related organ damage: an update, Alcohol and Alcoholism, Volume 56, Issue 1, Pages 8-16, https://doi.org/10.1093/alcalc/agaa085

Pai KG., Isoardi K., Buckely N., Chiew AL., Isbister G., Cairns R., Brown JA ... (2020) " Optimal way to achieve serum alkalinisation in tricyclic antidepressant overdose" Clinical Toxicology 58 (6): 618.

Pai KG., Isoardi K., Buckely N., Harris K., Becker T., Chiew A., Cairns R... (2020) " A Case series of flecainide poisoning" Clinical Toxicology 58 (6): 618.

Pai KG., Isoardi K., Buckley N., Becker T., Chiew A., Cairns R., Brown JA...(2020) "Effect of serum alkalinisation of QRS narrowing in tricyclc antidepressant poisoning" clinical Toxicology 58(6)618

Pathiraja V., Gawarammana I., Buckley N., Mohamed F., Jayamanne S...(2020) Clinical Toxicology 58 (4) 352-353.

Perananthan V, Mohamed F, Shahmy S, Gawarammana I, Dawson A, Buckley N. (2020) The clinical toxicity of imidacloprid self-poisoning following the introduction of newer formulations. Clin Toxicol (Phila). 22:1-4. doi: 10.1080/15563650.2020.1815760. Epub ahead of print. PMID: 32959700.

Perananthan, V, Shores, EA, Majumdar, A, et al. (2020) Quality of life indicators in hepatic encephalopathy following supplementation with branched chain amino acids and/or synbiotics: A post‐hoc analysis. GastroHep. 00: 1- 8. https://doi.org/10.1002/ygh2.439

Prior, K., Salemink, E., Wiers, R.W., Teachman, B.A., Piggott, M., Newton, N.C., Teesson, M., Baillie, A.J., Campbell, S. and Stapinski, L.A. (2020), Acceptability and Co‐Development of an Online Cognitive Bias Modification Intervention for Emerging Adults With Hazardous Alcohol Use and Social Anxiety: A Mixed Methods Study. Alcohol Clin Exp Res, 44: 2283-2297. https://doi.org/10.1111/acer.14452

Purcell‑Khodr, G., Lee, K., Conigrave, J., Webster, E., Conigrave, K. (2020). What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada. Addiction Science & Clinical Practice, 15(1), 31. https://doi.org/10.1186/s13722-020-00204-8

Raubenheimer J, Riordan B., Merrill J., Winter T, Ward R., Scarf D., Buckley N., (2020). Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum, International Journal of Drug Policy, Volume 90, 2021, 103083, ISSN 0955-3959, https://doi.org/10.1016/j.drugpo.2020.103083.

Reilly, R., Wand, H., McKetin, R., Quinn, B., Ezard, N., Dunlop, A., Conigrave, K., Treloar, C., Roe, Y., Gray, D., et al (2020). Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey. Drug and Alcohol Review, 39(6), 646-655. https://doi.org/10.1111/dar.13085

Riordan BC, Raubenheimer J, Ward RM, Merrill JE, Winter T, Scarf D. (2020) Monitoring the sentiment of cannabis-related tweets in the lead up to New Zealand's cannabis referendum. Drug Alcohol Rev. doi: 10.1111/dar.13184. Epub ahead of print. PMID: 33022132.

Riordan, B. C., Flett, J. A. M., Cody, L., Conner, T. S., & Scarf, D. (2020). The Fear of Missing Out (FoMO) and event-specific drinking: The relationship between FoMO and alcohol use, harm, and Blood Alcohol Concentration during large social events. Current Psychology.

Riordan, B., Winter, D., Day, C., Haber, P., Morley, K. (senior). (2021) What Are People Saying on Social Networking Sites About the Draft Australian Alcohol Consumption Guidelines? Medical Journal Australia, 214:Issue 3

Riordan, B.C., Cody, L., Flett, J.A.M. et al. (2020) The development of a single item FoMO (Fear of Missing Out) scale. Curr Psychol 39, 1215-1220. https://doi.org/10.1007/s12144-018-9824-8

Roberts J, White B, Attalla D, Ward S, Dunlop AJ. (2020) Rapid Upscale of Depot Buprenorphine (CAM2038) in Custodial Settings During the early covid‐19 pandemic in NSW, Australia. Addiction doi: 10.1111/add.15244.

Rombouts, S., Conigrave, J., Saitz, R., Haber, P., Morley, K (senior)(2020). Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: A systematic review. BMC Family Practice 21:260

Roxburgh A, Jauncey M, Day CA, Bartlett M, Cogger S, Dietze P, Nielsen S, Latimer J, Clark N. (2021) Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Harm Reduction Journal, 18:20

Scarf, D., Riordan, B. C., & Winter, T. (2020). The association between New Zealand adolescents' normative perceptions of pornography use and their frequency of pornography use. Medical Journal of New Zealand. Vol 133;1522

Scarf, D., Zimmerman, H., Boden, H., Graham, S., Winter, T., Riordan, B. C., Hunter, J. A. (2020). A comparison of prejudice toward people with mental illness after viewing the films Joker or Terminator. JAMA Open. 3(4):e203423.

Schaffer, A., Cairns, R., Brown, J., Gisev, N., Buckley, N., Pearson, S. (2020). Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine. Medical Journal of Australia, 212(7), 321-327. https://doi.org/10.5694/mja2.50552

Schwantes‐An, T.‐H., Darlay, R., Mathurin, P., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G.P., Eyer, F., Gleeson, D., Thompson, A., Muellhaupt, B., Stickel, F., Soyka, M., Goldman, D., Liang, T., Lumeng, L., Pirmohamed, M., Nalpas, B., Jacquet, J.‐M., Moirand, R., Nahon, P., Naveau, S., Perney, P., Botwin, G., Haber, P.S., Seitz, H.K., Day, C.P., Foroud, T.M., Daly, A.K., Cordell, H.J., Whitfield, J.B., Morgan, T.R., Seth, D. (2021), Genome‐wide association study and meta‐analysis on alcohol‐related liver cirrhosis identifies novel genetic risk factors. Hepatology. Accepted Author Manuscript. https://doi.org/10.1002/hep.31535

Sehgal, R., Kaur, S., Shasthry, S., Agrawal, T., Dwivedi, V., Seth, D., Ramakrishna, G., Sarin, S., Trehanpati, N. (2020). Natural Killer Cells contribute to pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells. Alcoholism: Clinical and Experimental Research, 44(1), 78-86. https://doi.org/10.1111/acer.14242

Seifert SA., Buckley N., Chan B., Chan TYK., Cumpston K., Kirschner RI. Megarbane B., Mullins M., Seger D., Thomas S., Vale A., Wilks MF. (2020) "Clinical Toxicology review metrics and expert reviewers, 2020" Clinical Toxicology vol59 (3) e1-3

Shihana F., Barron ML., Mohamed F., Seth D., Buckley N. (2021) "MicroRNAs in toxic acute kidney injury: Systematic scoping review of the current status". Pharmacology Research & Perspectives 9 (2) e00695

Shihana, F., Joglekar, M., Raubenheimer, J., Hardikar, A., Buckley, N., Seth, D. (2020). Circulating human microRNA biomarkers of oxalic acid-induced acute kidney injury. Archives of Toxicology, 94(5), 1725-1737. https://doi.org/10.1007/s00204-020-02679-5

Shihana, F., Mohamed, F., Joglekar, M., Hardikar, A., Seth, D., Buckley, N. (2020). Urinary versus serum microRNAs in human oxalic acid poisoning: Contrasting signals and performance. Toxicology Letters, 334, 21-26. https://doi.org/10.1016/j.toxlet.2020.09.003

Stapinski LA, Sannibale C, Subotic M, Rapee R., Teeson M., Haber P., Baillie A.(2020) Randomised controlled trial of integrated cognitive behavioural treatment and motivational enhancement for comorbid social anxiety and alcohol use disorders. Australian & New Zealand Journal of Psychiatry. doi:10.1177/0004867420952539

Sunderland, M., Forbes, M., Mewton, L., Baillie, A., Carragher, N., Lynch, S., Batterham PJ., Calear A., Chapman C., Newton NC., Teeson M., Slade, T. (2020). The structure of psychopathology and association with poor sleep, self-harm, suicidality, risky sexual behavior, and low self-esteem in a population sample of adolescents. Development and Psychopathology, 1-12. doi:10.1017/S0954579420000437

Surace, A., &†Riordan, B. C. (2020).It could get better: A response to reports of Sexual Minorities' life satisfaction in New Zealand. Australian and New Zealand Journal of Psychiatry, 54(3), 322-323

Tennant, E., Miller, E., Costantino, K. De souza D., Coupland H., Fotheringham P., Eastwood J. (2020) A critical realist evaluation of an integrated care project for vulnerable families in Sydney, Australia. BMC Health Serv Res 20, 995. https://doi.org/10.1186/s12913-020-05818-x

Toscano, R., Hudson, J. L., Baillie, A. J., Lyneham, H. J., & McLellan, L. F. (2020). Development of the Macquarie Anxiety Behavioural Scale (MABS): a parent measure to assess anxiety in children and adolescents including young people with autism spectrum disorder. Journal of Affective Disorders, 276, 678-685. https://doi.org/10.1016/j.jad.2020.06.076

Tremonti C, Volovets A, Jamshidi N, Buckley N, Dawson A, Conigrave K, Haber P. (2020)"Comment on pill testing review." Intern Med J. 50(12):1596-1597. doi:10.1111/imj.15115. PMID: 33354882

Tulloch, K., Baillie, A. (2020). Development and Initial Evaluation of the Craving Metacognition Scale. Australian Psychologist, 55(1), 38-49. https://doi.org/10.1111/ap.12439

Uribe Guajardo, MG., Baillie, A., Louie, E., Giannopoulos, V., Wood, K., Riordan, B., Haber, P., Morley, K. (2020). Application of the Non-adoption, Abandonment, Scale-up, Spread and, Sustainability (NASSS) Framework to evaluate the role of technology in the Pathways to Comorbidity Care (PCC) implementation project to improve management of comorbid substance use and mental disorders. PsyArXiv. https://psyarxiv.com/t9rs4/. doi:10.31234/osf.io/t9rs4.

Vichitkunakorn, P., Conigrave, K.M., Geater, A.F. et al. (2020) A Context-Specific Instrument to Record Drinking Behaviour: A Pilot Study on Implications of Identifying the Context of Risky Drinking. Community Ment Health J. https://doi.org/10.1007/s10597-020-00629-0

Ward, R.M., Riordan, B.C., Merrill, J.E. and Raubenheimer, J. (2021), Describing the impact of the COVID‐19 pandemic on alcohol‐induced blackout tweets. Drug Alcohol Rev.. https://doi.org/10.1111/dar.13186

Weatherall, T., Conigrave, K., Conigrave, J., Lee, K. (2020). What is the prevalence of current alcohol dependence and how is it measured for Indigenous people in Australia, New Zealand, Canada and the United States of America? A systematic review. Addiction Science & Clinical Practice, 15(1), 32. https://doi.org/10.1186/s13722-020-00205-7

Whitfield, JB., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G., Eyer, F., Gleeson, D., Thompson, A.,Stickel, F., Soyka, M., Muellhaupt, B., Daly, AK., Cordell, H., Foroud, T., Lumeng, L., Pirmohamed, M., Nalpas, B., Jacquet, J., Moirand, R., Nahon, P., Naveau, S., Perney, P., Haber, P., Seitz, H., Day, C Mathurin, P., Morgan, T., Seth, D. (2021) Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers, The American Journal of Gastroenterology: January 2021 - Volume 116 - Issue 1 - p 106-115 doi: 10.14309/ajg.0000000000000833

Wijerathna T., Mohamed F., Gawarammana IB, Wunnapuk K, Dissanayake DM, Shihana F, Buckley N. (2020) Cellular injury leading to oxidative stress in acute poisoning with potassium permanganate/oxalic acid, paraquat, and glyphosate surfactant herbicide,Environmental Toxicology and Pharmacology,Volume 80,2020,103510,ISSN 1382-6689,https://doi.org/10.1016/j.etap.2020.103510.

Winter, T., Riordan, B.C., Pakpour, A.H. et al. (2020) Evaluation of the English Version of the Fear of COVID-19 Scale and Its Relationship with Behavior Change and Political Beliefs. Int J Ment Health Addiction. https://doi.org/10.1007/s11469-020-00342-9

Winter DT, White N, Geiger B, Haber PS, Day CA. (2021) Should we be using e-vouchers to compensate research participants? Acceptability among opioid agonist treatment clients. Drug and Alcohol Review (accepted).

Wong A., Yarema M., Isbister GK., Sivilotti MLA., McNulty R., Chiew A...(2020) Comparison of adverse reactions to a 2 vs 3 bag IV acetylcysteine regimen during treatment of paracetamol overdose. Clinical Toxicology 58 (4) 326-327.

Wood, K., Giannopolous, V. Baillie, A. Uribe, G. Louie, E., Haber, P. Morley, K (senior) (2020). The role of clinical champions in facilitating the use of evidence-based practice in drug and alcohol and mental health settings: A systematic review. Implementation Research and Practice. doi:10.1177/2633489520959072

Wylie, C., Daniels, B., Brett, J., Pearson, S., Buckley, N. (2020). A national study on prescribed medicine use in Australia on a typical day. Pharmacoepidemiology and Drug Safety, 29(9), 1046-1053. https://doi.org/10.1002/pds.5093

Zamani, N., Buckley, N., Hassanian-Moghaddam, H. (2020). Naloxone should remain the appropriate antidote to treat opioid overdose (reply). Critical Care 24:173

Zheng, D., Brett, J., Daniels, B., Buckley, N., Pearson, S., Schaffer, A. (2020). Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014-2017). Drug and Alcohol Review, 39(5), 575?582. https://doi.org/10.1111/dar.13086

Zimmerman, H., Riordan, B. C., Winter, T., Bartonicek, A., & Scarf, D (2021). Neuroessentialism and mental illness stigma in psychology and non-psychology students. New Zealand Journal of Psychology.

2019

Editorials/Reports/Guidelines

Australian Treatment Guidelines for Alcohol-related Problems. Submitted (2020) - Funded by Department of Health, Australian Government (CI Haber P, Content contributions by multiple members of DHS research)

Buckley NA, Dawson AH, Whyte IM. Hypertox. Assessment and Treatment of Poisoning. A computerised educational text published in html and an essential text for Poisons Information Services in Australia. Also available on the Internet at "www.hypertox.com". Latest version Hypertox 2019.

Chiew A, Wong A, Pomerlau A, Isoardi K, Soderstrom J, Reith D, Buckley NA. Summary statement: updated guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. Medical Journal of Australia 2019; doi: 10.5694/mja2.50428 [Epub ahead of print] IF:5.332

Coupland H, Moensted M, Day C, on behalf of the SUPPS working group (2019). Research Report: Developing a model of care for Substance Use in Pregnancy and Parenting Services. Submitted to the Sydney Local Health District May 2019.

Coupland H, Moensted M, Day C, on behalf of the SUPPS working group (2019). Model of Care: Substance Use in Pregnancy and Parenting Services, Sydney Local Health District. Submitted to the Sydney Local Health District May 2019.

Day CA and Moensted M (2019). A Health Justice Partnership in Inner-city Sydney: Attendance patterns and client perceptions. Final Report submitted to Redfern Legal Centre Sydney.

Refereed Journal Articles

Alahakoon C, Dassanayake TL, Gawarammana IB, Weerasinghe VS, Buckley NA. Differences between organophosphates in respiratory failure and lethality with poisoning post the 2011 bans in Sri Lanka. Clinical Toxicology 2019; doi.org/10.1080/15563650.2019.1660782 [Epub ahead of print] IF:4.398

Al Ansari M, Dawson A and Conigrave K (2019). Alcohol: from Mesopotamia to modern Iraq. Journal of Ethnicity in Substance Abuse: 1-23. https://doi.org/10.1080/15332640.2019.1657541

Al-Ansari B, Thow A-M, Mirzaie M, Day CA, Conigrave KM. (2019) Alcohol policy in Iran: policy content analysis. International Journal of Drug Policy. Accepted 19/07/2019.

Al-Ansari F, Al Ansari M, Hill-Cawthorne GA, Abdulzahra MS, Al-Ansari MB, Al-Ansari B, Rashid H, Negin J and Conigrave KM (2019). Arbaeen public health concerns: A pilot cross-sectional survey. Travel Medicine and Infectious Disease: 101546. https://doi.org/10.1016/j.tmaid.2019.101546

Albuquerque PL, Silva Jr GB, Meneses GC, Martins AM, Lima D, Raubenheimer J, Shihana F, Buckley N, Daher E. Acute Kidney Injury Induced by Bothrops Venom: Insights into the Pathogenic Mechanisms. Toxins 2019;11(3):E148. doi:10.3390/toxins11030148 IF:3.895

Arkell TR, Kevin R, Stuart J, Lintzeris N, Haber P, Ramaekers JG, McGregor IS. Detection of Δ9 THC in oral fluid following vaporised cannabis with varied cannabidiol (CBD) content: an evaluation of two point-of-collection testing devices. Drug Test Anal. 2019 Aug 23. doi: 10.1002/dta.2687. [Epub ahead of print].

Arkell TR, Lintzeris N, Kevin R, Ramaekers JG, Vandrey R, Irwin C, Haber PS, McGregor IS. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology, 2019; 236(9): 2713-2724.

Belackova V, Salmon AM, Jauncey M, Day C. (2019). Safer injecting facilities - is the research there? A comment on Caulkins et al 2019. (letter). Addiction. Accepted 29/10/2019.

Belackova V, Salmon, A, Day CA, Ritter A, Shanahan M, Hedrich D, Kerr T, Jauncey M. (2019). Drug Consumption Rooms: a systematic review of evaluation methodologies. Drug and Alcohol Review, 38, 406-422.

Belackova V, Silins E, Salmon AM, Jauncey M, Day C. (2019) "Beyond safer injecting" - health and social needs and acceptance of support among clients of a supervised injecting facility. International Journal of Environmental Research and Public Health, 16(11): 1-12.

Bell J, Pearson SA, Paget SP, Nielsen T, Buckley NA, Collins J, Nassar N. Prescription opioid use in Australian children and adolescents: a national population-based study. Lancet Child and Adolescent Health 2019; 3(12):881-888. doi: 10.1016/S2352-4642(19)30329-3

Bethmont, A., Harper, C. E., Chan, B. S. H., Dawson, A. H. & McAnulty, J. Increasing illicit use of nitrous oxide in presentations to NSW emergency departments. The Medical Journal of Australia 211, 429-429. e1 (2019).

Blair C, Tremonti C, Edwards L, Haber PS, Halmagyi GM. Vitamin B12 supplementation futile for preventing demyelination in ongoing nitrous oxide misuse. Med J Aust. 2019 Nov;211(9):428-428.e1. doi: 10.5694/mja2.50371. Epub 2019 Oct 17. No abstract available.

Borruso LD, Buckley NA, Kirby K, Carter G, Pilgrim J, Chitty KM. Acute alcohol consumption and hospital treated deliberate self-poisoning; is there a difference in subsequent self-harm? Suicide and Life-threatening Behaviour 2019; 49(1):293-302. doi: 10.1111/sltb.12443. IF:3.032

Bracken L, Chan B, Buckley NA. Physiologically based pharmacokinetic modelling of acute digoxin toxicity and the effect of digoxin-specific antibody fragments. Clinical Toxicology 2019;57(2):117-124. doi:10.1080/15563650.2018.1503288 IF:4.398

Brett J, Wylie C, Raubenheimer J, Isbister GK, Buckley NA. The relative lethal toxicity of pharmaceutical and illicit substances; A 16-year study of the Greater Newcastle Hunter Area, Australia. British Journal of Clinical Pharmacology 2019; 85:2098-2107. doi.org/10.1111/bcp.14019. IF:3.867

Brown JA, Wylie CE, Cairns R, Buckley NA. Recognising injuries related to needle stick injury in farmers: the importance of identifying high‐pressure injections with mineral oil. Medical Journal of Australia 2020;212(2):94. doi:10.5694/mja2.50448 IF:5.332

Bruno C, Pearson SA, Daniels B, Buckley NA, Schaffer A, Zoega H. Failing the acid test - could National QUM campaigns change PPI use in Australia? BMJ Quality and Safety 2019; doi:10.1136/bmjqs-2019-009897 [Epub ahead of print]

Buckley NA, Cheng S, Isoardi K, Chiew AL, Siu W, Vecellio E, Chan BS. Haemodialysis for Lithium Poisoning: translating EXTRIP recommendations into practical guidelines. British Journal of Clinical Pharmacology 2020; doi: 10.1111/bcp.14212. [Epub ahead of print] IF:3.867

Butler K, Larney S. Day CA, Burns L. (2019). Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system. Drug and Alcohol Review, 38(3): 264-269.

Byrne SP, Haber P, Baillie A, Giannopolous V & Morley K (2019). Cue Exposure Therapy for Alcohol Use Disorders: What Can Be Learned from Exposure Therapy for Anxiety Disorders?, Substance Use & Misuse, DOI: 10.1080/10826084.2019.1618328

Byrne, S., Haber, P., Baillie, A., Costa, S.J., Fogliati, V., Morley, K.C (senior) (2019). Systematic Reviews of Mindfulness and Acceptance and Commitment Therapy for Alcohol Use Disorder: Should we be using Third Wave Therapies? Alcohol and Alcoholism, in press

Byrne, S., Haber, P., Baillie, A., Giannopolous, V, Morley, K.C (senior). (2019) Cue Exposure Therapy for Alcohol Use Disorders: What Can Be Learned from Exposure Therapy for Anxiety Disorders? Substance Use and Misuse, 54(12):2053-2063

Cairns R, Brown J, Buckley NA. Adolescent self-harm: Over-the-counter medicines fly under-the-radar. Australian Prescriber 2019; 42(5):151. doi: 10.18773/austprescr.2019.061

Cairns R, Brown J, Lachireddy K, Wylie C, Robinson J, Lynch AM, Dawson AH, Buckley NA. Button battery exposures in Australian Children: a prospective observational study highlighting the role of poisons centres. Clinical Toxicology 2019; 57(6):404-410. doi: 10.1080/15563650.2018.1537492 IF:4.398

Cairns R, Brown JA, Buckley NA. Clonidine exposures in children under 6 (2004-2017): a retrospective study. Archives of Disease in Childhood 2019; 104(3):287-291. IF:3.158

Cairns R, Brown JA, Lachireddy K et al. Button battery exposures in Australian children: a prospective observational study highlighting the role of poisons information centres. Clin Toxicol (Phila). 20191-7.

Cairns R, Brown JA, Wylie CE, Dawson AH, Isbister GK, Buckley NA. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004-2017. Medical Journal of Australia 2019; 211(5):218-223. doi:10.5694/mja19.00334. IF:5.332

Cairns R, Karanges E, Wong A, Brown J, Robinson J, Pearson SA, Dawson AH, Buckley NA. Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: a population based retrospective cohort study in Australia. BMJ Open 2019; 9:e026001 doi:10.1136/bmjopen-2018-026001 IF:2.376

Cairns R, Karanges EA, Wong A, Brown JA, Robinson J, Pearson S-A, Dawson AH & Buckley NA. Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: a population-based retrospective cohort study in Australia. BMJ Open. 2019;9:e026001.

Cairns R, Raubenheimer J, Brown JA, McArdle K, Buckley NA. 2,4-Dinitrophenol (DNP) exposures and deaths in Australia following 2017 up-scheduling. Medical Journal of Australia 2020; (accepted Nov 2019) IF:5.332

Cairns R, Schaffer A, Pearson SA, Ryan N, Buckley NA. Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018) - in reply. Addiction 2019; 114(3):572-573. doi: 10.1111/add.14531 IF:6.851

Cairns R, Schaffer A, Pearson SA, Ryan N, Buckley NA. Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings. Addiction 2019; 114:1026-1034. doi:10.1111/add.14412 IF:6.851

Cairns R, Schaffer AL, Brown JA, Pearson S-A, Buckley NA. Codeine use and harms in Australia: evaluating the effects of re-scheduling. Addiction 2019; doi:10.1111/add.14798 [Epub ahead of print] IF:6.851

Chan B, Isbister GK, Page C, Isoardi K, Chiew A, Kirby K, Buckley NA. Clinical Outcomes from early use of anti-digoxin antibodies versus observation in chronic digoxin poisoning. (ATOM-4). Clinical Toxicology 2019; 57(7):638-643. doi:10.1080/15563650.2018.1546010 IF:4.398

Cheng S, Buckley NA, Siu W, Chiew AL, Vecellio E, Chan BS. Seasonal and Temperature Effect on Serum Lithium Levels. ANZ J Psychiatry 2019;doi:10.1177/00048674198891 [Epub ahead of print] IF:5.000

Chiew A, James L, Isbister G, McArdle K, Pickering J, Chan B, Buckley NA. Acetaminophen-Protein Adducts following Paracetamol Overdose (ATOM-5). J Hepatology 2020; doi:10.1016/j.jhep.2019.10.030 [Epub ahead of print] IF:18.496

Chiew AL, Buckley NA. SNAP - A Large Step in the Move towards Personalised Dosing of Acetylcysteine. EClinical Medicine 2019;11:3-4. doi: 10.1016/j.eclinm.2019.04.012

Chiew AL, Domingo G, Buckley NA, Stathakis P, Ress K, Roberts D. Hepatotoxicity in a child following an accidental overdose of liquid acetaminophen. Clinical Toxicology 2020;doi: 10.1080/15563650.2020.1722150. (accepted Jan 2020)

Conigrave J, KSK L, Zheng C, Wilson S, Perry J, Chikritzhs T, Slade T, Morley K, Room R, Callinan S, Hayman N and Conigrave K (in press, accepted 6 February 2020). Drinking risk varies within and between Australian Aboriginal and Torres Strait Islander samples: A meta-analysis to` identify sources of heterogeneity. Addiction.

Conigrave, J., Lee1, K., Slade, T., Morley, K., Haber, P., Wilson, S., Chikritzhs, T., Room, R., Callinan, S., Hayman, N. & Conigrave, K (2020). A meta-analysis of Australian Aboriginal drinking patterns. Addiction, In press

Coupland H, Moensted M, Khanlari S, Reid S, White B, Eastwood J, Haber P and Day C. Developing a model of care for Substance Use in Pregnancy and Parenting Services in Sydney, Australia. International Journal of Integrated Care. 2019;19(4):141. DOI: http://doi.org/10.5334/ijic.s3141

Coupland H, Moensted, ML, Eastwood J, Haber PS, Reid S, White B, Day CA. (2019). Making integrated care work: Contested clinical spaces in Substance use in pregnancy and Parenting services, Sydney, Australia (paper 96). Drug and Alcohol Review, 38 (Suppl. 1): S38. DOI: 10.1111/dar.12991

Coupland H, White B, Bates A, Park JN, Iversen J, Maher L. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia. Drug Alcohol Rev, 2019; 8, 77-184

de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Review.

Dowsett M, Islam MM, Ganora C, Day CA, Lee KK, Dawson A, Joseph T, White A, Freeburn B and Conigrave KM (2019). Asking young Aboriginal people who use illicit drugs about their healthcare preferences using audio-computer assisted self-interviewing. Drug and Alcohol Review 38: 482-493.

Dzidowska M, Lee KK, Wylie C, Bailie J, Percival N, Conigrave JH, Hayman N and Conigrave KM (2020) A systematic review of approaches to improve practice, detection and treatment of unhealthy alcohol use in primary health care: a role for continuous quality improvement. BMC Family Practice 21 DOI: doi.org/10.1186/s12875-020-1101-x.

Egunsola O, Raubenheimer J, Buckley NA. Years of life lost or years of potential life lost: Implications for the estimation of the burden of disease. BMJ open 2019; 9:e027825. doi:10.1136/bmjopen-2018-027825. IF:2.376

Egunsola O, Wylie CE, Chitty KM, Buckley NA. A systematic review of the efficacy and safety of gabapentin and pregabalin for pain in children and adolescents. Anaesthesia and Analgesia 2019; 128(4):811-819. doi:10.1213/ANE.0000000000003936. IF:3.827

Falster MO, Buckley NA, Brieger D, Pearson SA. Antihypertensive polytherapy in Australia: prevalence of inappropriate combinations, 2013-2018. J Hypertension 2020;(accepted Feb 5th 2020) IF:4.209

Frost, Michael; Bailey, Genie; Lintzeris, Nicholas; Strang, John; Dunlop, Adrian; Nunes, Edward; Jansen, Jakob; Frey, Lars; Weber, Bernd; Haber, Paul; Oosman, Sonia; Kim, Sonnie; Tiberg, Fredrik. Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult outpatients with opioid use disorder. Addiction, in press15 April 2019.

Garami J, Valikhani A, Parkes D, Haber P, Mahlberg J, Misiak B, Frydecka D, Moustafa AA. Examining Perceived Stress, Childhood Trauma and Interpersonal Trauma in Individuals with Drug Addiction. Psychol Rep. 2019 Apr;122(2):433-450.

Haber, PS, Topp, L, Day CA, Winter, DT, Dunlop AJ, Graham RI, Lintzeris N. (2019). Symposium: the NSW drug and alcohol clinical research and improvement network: Enhancing clinical research capacity and productivity across the alcohol and other drug sector (Paper 143). Drug and Alcohol Review, 38 (Suppl. 1): S7. DOI: 10.1111/dar.12991

Hallinan R, Elsayed M, Espinoza D, Veillard AS, Morley KC, Lintzeris N, Haber P. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment. Subst Use Misuse. 2019;54(10):1589-1598. doi: 10.1080/10826084.2018.1552298. Epub 2019 May 26. PMID: 31131668

Harrison KH, Lee KK, Dobbins T, Wilson S, Hayman N, Ivers R, Haber PS, Conigrave JH, Johnson D, Hummerston B, Gray D and Conigrave KM (2019) Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial. BMJ Open 9, e030909 DOI: http://dx.doi.org/10.1136/bmjopen-2019-030909

Hassanian-Moghaddam H, Zamani N, Roberts DM, Brent J, McMartin K, Aaron C, Eddleston M, Dargan PI, Olson K, Nelson L, Bhalla A, Hanston P, Jacobsen D, Megarbane B, Balali-Mood M, Buckley N, Zakharov S, Paasma R, Jarwani B, Mirafzal A, Salek T, Hovda KE. Consensus statements on the approach to patients in a methanol poisoning outbreak. Clinical Toxicology 2019; 57(12):1129-1136. doi: 10.1080/15563650.2019.1636992. IF:4.398

Hunt, G., Cleary, M., Morley, K.C., Siegfried, N. (2019). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, Issue 12. Art. No.: CD001088. DOI: 10.1002/14651858.CD001088.pub4

Huynh A, Cairns R, Brown JA et al. Health care cost savings from Australian Poisons Information Centre advice for low risk exposure calls: SNAPSHOT 2. Clinical toxicology. 2019 1-6

Huynh A, Cairns R, Dawson AH, Jan S, Brown J, Robinson J, Wylie C, Lynch AM, Buckley NA. Health care cost savings from Australian Poisons Information Centre advice for low risk exposure calls: SNAPSHOT 2. Clinical Toxicology 2019; doi:10.1080/15563650.2019.1686513 [Epub ahead of print] IF:4.398

Jamshidi N, Dawson A. The hot patient: acute drug-induced hyperthermia. Australian prescriber. 2019;42:24.

Jamshidi N, Morley KC, Cairns R, Dawson A, Haber PS. A review of baclofen overdoses in Australia: Calls to a Poisons Information Centre and a case series. Alcohol and Alcoholism, 54(1):73-78, 2019.

Jamshidi, N., Morley, K., Cairns, R., Dawson., A., Haber., P. (2019) A review of baclofen overdoses in Australia: Calls to a Poisons Information Centre and a case series. Alcohol Alcoholism, 54(1):73-78. doi: 10.1093/alcalc/agy082

Kealy-Bateman W, McDonald A, Haber PS, Green T, White B, Sundakov V, O'Cionnaith C, Glozier N. Development of a joint mental-health and drug health assessment unit and short-stay unit. Australas Psychiatry. 2019 May 20:1039856219848825. doi: 10.1177/1039856219848825.

Knipe, D. Metcalfe,C. Hawton,K. Pearson,M. Dawson, A. Jayamanne,S. Konradsen F, Eddleston,M. Gunnell, D. Risk of suicide and repeat self-harm after hospital attendance for non-fatal self-harm in Sri Lanka: a cohort study. The Lancet Psychiatry 6, 659-666 (2019).

Kristie Harrison, KS Kylie Lee, Timothy Dobbins, Scott Wilson, Noel Hayman, Rowena Ivers, Paul S. Haber, James H Conigrave, David Johnston, Beth Hummerston, Dennis Gray, Katherine M Conigrave. Supporting Aboriginal Community Controlled Health Services with delivering alcohol care: a cluster randomised controlled trial. BMJ Open, in press Sept 2019.

L Ross, PS Haber, CA Day. Identification of smoking status in the Census is needed, but what about the healthcare system? Australian and New Zealand Journal of Public Health. 2019 Feb;43(1):96. (Published Letter)

Lee KK, Conigrave JH, Al Ansari M, Wilson S, Perry J, Zheng C, Freeburn B, Room R, Callinan S, Hayman N, Chikritzhs T, Slade T, Gray D and Conigrave KM (2019) Acceptability and feasibility of a computer-based application to help Aboriginal and Torres Strait Islander Australians describe their alcohol consumption. Journal of Ethnicity in Substance Abuse, 1-18 DOI: https://doi.org/10.1080/15332640.2019.1579144.

Lee KK, Conigrave JH, Callinan S, Wilson S, Room R, Perry J, Slade T, Chikritzhs TN, Hayman N, Weatherall T, Leggat G, Gray D and Conigrave KM (2019) Asking about the last four drinking occasions on a tablet computer as a way to record alcohol consumption in Aboriginal and Torres Strait Islander Australians: a validation. Addiction Science and Clinical Practice 1415 DOI: https://doi.org/10.1186/s13722-019-0148-2.

Lee KK, Harrison M, Wilson S, Miller W, Perry J and Conigrave KM (2019). Integrated learning in a drug and alcohol university degree for Aboriginal and Torres Strait Islander adults: a case study. AlterNative: An International Journal of Indigenous Peoples 15: 44-51.

Lee KSK, Conigrave JH, Wilson S, Perry J, Callinan S, Room R, Chikritzhs TN, Slade T, Hayman N, Leggat G and Conigrave KM (2019). Short screening tools for risky drinking in Aboriginal and Torres Strait Islander Australians: modified AUDIT-C and a new approach. Addiction Science and Clinical Practice 14: 12.

Lee KSK, Conigrave JH, Wilson S, Perry J, Hayman N, Zheng C, Ansari MA, Doyle M, Room R, Chikritzhs TN, Callinan S, Slade T and Conigrave KM (2019) Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self-reported on the Grog Survey App: a stratified sample. BMC Informatics and Decision Making 19, 180 DOI: https://doi.org/10.1186/s12911-019-0879-8.

Lintzeris N, Monds LA, Bravo M, Read P, Harrod ME, Gilliver R, Wood W, Nielsen S, Dietze PM, Lenton S, Shanahan M, Jauncey M, Jefferies M, Hazelwood S, Dunlop AJ, Greenaway M, Haber P, Ezard N, Malcom A. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives. Drug Alcohol Rev. 2019 Nov 27. doi: 10.1111/dar.13015. [Epub ahead of print]

Logge WB, Morris RW, Baillie AJ, Haber PS, Morley KC. Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals. Psychopharmacology (Berl). 2019 Feb 20. doi: 10.1007/s00213-019-05192-5. [Epub ahead of print]

Logge, W., Baillie, A., Haber, P., Morley, K., (senior) (2020). Baclofen Modulates Psychophysiological Responses to Appetitive Cues in Treatment-seeking Alcohol Use Disorder Individuals. Human Psychopharmacol, In press

Logge, W., Baillie, A., Morris, R., Fraser, I., Haber, P., Morley, K.C (senior) (2019). Baclofen reduces alcohol cue-induced fMRI brain activation in treatment-seeking alcohol dependent individuals, Psychopharmacology, in press

Logge, W., Morley, K., Haber, P (2020). GABAB receptors and alcohol use disorders: clinical studies, Behavioral Neurobiology of GABAB Receptor Function, Current Topics in Behavioral Neurosciences, In press

Logge, W., Morley, K., Morris, R., Haber, P., Baillie, A. Executive Functioning is Associated with Regulation of Psychophysiological Responses in Non-Treatment-Seeking Drinkers: A Laboratory Cue Reactivity Study (2020). ACER, In press

Logge, W., Morley, K.C, Haber, P., Baillie, A. (2019) Executive functioning moderates responses to appetitive cues: a study in severe alcohol use disorder. Alcohol Alcoholism, 54(1):38-46. doi: 10.1093/alcalc/agy083.

Louie, E., Barrett, E., Baillie, A., Haber, P., Morley, K.C. (senior) (2020). Implementation of evidence-based practice in drug and alcohol services: Protocol for systematic review Systematic Reviews, In press

Makdessi CJ, Day CA, Chaar B. (2019) Challenges faced with opioid prescriptions in the community setting - the pharmacist's perspective. Research in Social and Administrative Pharmacy, 15(8): 966-973.

Moensted ML & Day CA. (2019). Drug and alcohol services for the Muslim and Arabic speaking Community in Sydney (Paper 34). Drug and Alcohol Review, 38 (Suppl. 1): S74. DOI: 10.1111/dar.12991

Moensted ML, Coupland H, Reid S, White B, Day CA. (2019). Increasing access to justice for marginalised groups who use drugs: What works in service delivery? (Paper 32). Drug and Alcohol Review, 38 (Suppl. 1): S73. DOI: 10.1111/dar.12991

Moensted ML, Coupland H, Reid S, White B, Day CA. (2019). Welfare interventions in the context of mandatory reporting policies: qualitative findings (Paper 33). Drug and Alcohol Review, 38 (Suppl. 1): S74. DOI: 10.1111/dar.12991

Moensted, MM & Day CA. (2020). Welfare interventions in the context of support and control: the experiences of marginalised people who use drugs. Health and Social Care in the Community: DOI: 10.1111/hsc.12946

Morley KC, Lagopoulos J, Logge W, Chitty K, Moustafa AA, Haber PS. Brain N-Acetyl Aspartate and associations with cognitive impairment in alcohol dependent patients. J Clin Exp Neuropsychol. 2019 Nov 7:1-7. doi: 10.1080/13803395.2019.1685078. [Epub ahead of print]

Morley, K.C. Rombouts, S. Haber, P.S. (2020). Pharmacotherapies for alcohol dependence. Guidelines For The Treatment of Alcohol Problems, Australian Government Department for Health and Aging, Chapter 7, In press

Morley, K.C., Lagopolous, J., Logge, W., Chitty, K., Haber, P. (2019). Brain NAA levels in patients with alcohol dependence and association with cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 42(2):111-117

Murnion B and Conigrave KM (2019). Pregabalin misuse: the next wave of prescription medication problems [invited editorial]. Medical Journal of Australia 210: 72-73.

Narayan SW, Litchfield M, McLachlan A, Le Couteur D, Buckley NA, Pearson S, Zoega H. Anticholinergic use in older people initiating on anti-dementia medicines. British Journal of Clinical Pharmacology 2019;85:1957-63. doi:10.1111/bcp.13976 IF:3.867

Peacock A, Gisev N, Memedovic S, Larance B, Brown J, Cairns R, Buckley N, Farrell M, Degenhardt L. Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study. Drug and Alcohol Dependence 2020; 206:107697. doi: 10.1016/j.drugalcdep.2019.107697 IF:3.466

Peacock A, Larance B, Bruno R, Pearson SA, Buckley NA, Farrell M, Degenhardt L. Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations. Addiction 2019; 114(3):404-405. doi: 10.1111/add.14556. IF:6.851

Peacock A, Larance B, Bruno R, Pearson SA, Buckley NA, Farrell M, Degenhardt L. Post-Marketing Studies of Pharmaceutical Opioid Abuse-Deterrent Formulations: A Framework for Research Design and Reporting. Addiction 2019; 114(3):389-399 doi: 10.1111/add.14380. IF:6.851

Pearson SA, Buckley NA, Stamatakis E. Exercise trials for blood pressure control: Keeping it REAL. Br J Sports Med 2019;53(23):1443-4. doi: 10.1136/bjsports-2019-100787. IF:11.645

Perananthan V, Wijerathna TM, Gawarammana IB, Nagaratham A, Dawson AH, Buckley NA. Two rare case reports of ingestion of ammonium hydroxide and novel study of gastrointestinal toxicity. BMJ Open Gastroenterology 2019; 6:e000259. doi:10.1136/bmjgast-2018-000259

Power J, Salmon AM, Latimer J, Jauncey M, Day CA. (2019). Adverse events and client characteristics associated with the injection of buprenorphine at the Uniting Medically Supervised Injecting Centre, Sydney. Substance Use and Misuse. https://doi.org/10.1080/10826084.2019.1600147

Pushpakumara PHGJ, Thennakoon SUB, Rajapakse TN, Abeysinghe R, Dawson AH. A prospective study of repetition of self-harm following deliberate self-poisoning in rural Sri Lanka. PLoS One. 2019;14: e0199486.

Raichand S, Pearson SA, Zoega H, Buckley NA, Havard A. Utilisation of teratogenic medicines before and during pregnancy in Australian women. Australian & New Zealand Journal of Obstetrics and Gynaecology 2019; doi:10.1111/ajo.13044 [Epub ahead of print] IF:1.455

Ratnayake I, Mohamed F, Buckley NA, Gawarammana IB, Dissanayake DM, Chathuranga U, Munasinghe M, Maduwage K, Jayamanne S, Endre ZH, Isbister GK. Early identification of acute kidney injury in Russell's viper (Daboia russelii) envenoming using renal biomarkers. PLoS Neglected Tropical Diseases 2019;13(7):e0007486. doi:10.1371/journal.pntd.0007486. IF:4.487

Reilly R, McKetin R, Wand H, Butt J, Smout M, Ezard N, Conigrave K, Clark Y, Quinn B, Treloar C, Gray D, Dunlop A, Roe Y and Ward J (2019). A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among Aboriginal and Torres Strait Islander People: Protocol for a randomized wait-list controlled trial. JMIR Research Protocols 8: e14084.

Rombouts, S. Baillie, A., Haber, P. Morley, K.C (senior). (2019). Clinical predictors of response to baclofen in the treatment of alcohol use disorder: Results from the BacALD trial. Alcohol and Alcoholism 54(3):272-278.

Rombouts, S., Conigrave, J., Louie, E., Haber, P., Morley, K.C. (senior). (2019) Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: Protocol for systematic review. Systematic Reviews, 8, 275

Ross L, Haber PS, Day CA. (2019) Identification of smoking status in the Census is needed, but what about the healthcare system? (letter). Australian and New Zealand Journal of Public Health, 43(1): 96.

Sahar Bajis, Jason Grebely, Behzad Hajarizadeh, Tanya Applegate, Mary Harrod, Jude Byrne, Adrian Dunlop, Nicky Bath, Phillip Read, Marianne Jauncey, Patricia Collie, Michael Edwards, Carla Gorton, Nadine Ezard, Jeremy Hayllar, Victoria Cock, Steven Peterson, Claire Thompson, Martin Weltman, Paul Haber, Thao Lam, Alison D Marshall, Marianne Martinello, Carla Treloar, Lisa Maher and Gregory J Dore on behalf of the LiveRLife Study Group. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes among people who inject drugs in Australia: The LiveRLife study. J Viral Hepat. 2019 Nov 7. doi: 10.1111/jvh.13233. [Epub ahead of print]

Schaffer A, Buckley NA, Cairns R, Pearson SA. Change in prescribing patterns following a national policy to curb inappropriate alprazolam prescribing in Australia. JAMA Open Network 2019;2(9):e1911590. doi:10.1001/jamanetworkopen.2019.11590

Schaffer A, Karanges E, Buckley NA, Wilson A, Degenhardt L, Larance B, Pearson SA. Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations. Pharmacoepidemiology and Drug Safety 2019;28:97-105. doi:10.1002/pds.4683 IF:2.870

Schaffer AL, Cairns R, Brown J, Gisev N, Buckley NA, Pearson SA. Trends in national pharmaceutical sales after rescheduling over-the-counter codeine to a prescription-only medicine. Medical Journal of Australia 2020; (accepted Dec 17 2019) IF:5.332

Schaffer AL, Zoega H, Tran DT, Buckley NA, Pearson S, Havard A. Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. ANZ Journal of Psychiatry 2019; 53(12):1208-1221. doi.org/10.1177/0004867419847764. IF:5.000

Sheynin, J., Myers, C. E., Ghafar, F., Morris,A.N., Morley, K.C., Haber, P. C., Moustafa, A. A. (2019). Greater escape and approach behaviors in treated alcohol-dependent males. Journal of Clinical and Experimental Neuropsychology, 41(6): 601-614.

Sheynin, J., Myers, C. E., Ghafar, F., Morris,A.N., Morley, K.C., Haber, P.S., Moustafa, A. A. (2019). A pilot study of escape and approach behaviors in treated alcohol-dependent males. Journal of Clinical and Experimental Neuropsychology. 2019 Aug;41(6):601-614.

Shihana F, Worek F, Rathgamage S, Dassanayake G, Dhanasiri J, Buckley NA. Evaluation of the "ChE check mobile" accuracy in measurement of acetylcholinesterase and plasma cholinesterase in anticholinesterase pesticide poisoning. Clinical Toxicology 2019; 57(6):411-414. doi:10.1080/15563650.2018.1530778. IF:4.398

Sibanda, N., Kornhaber, R., Hunt, G., Morley, K., Cleary, M. (2019) Prevalence and risk factors of emergency department presentations with methamphetamine intoxication or dependence: a systematic review and meta-analysis. Issues in Mental Health Nursing, 26: 1-12

Silva A, Sedgwick EM, Siribaddana S, Dassanayake V, Pilapitiya S, Weerawansa P, Buckley NA, Isbister GK. Sub-clinical neuromuscular dysfunction after envenoming by Merrem's hump-nosed pit viper (Hypnale hypnale). Toxicology Communications 2019:3(1):23-8. doi: 10.1080/24734306.2018.1560991.

Sukhanga M, Junkuya A, Buckley NA, Mohamed F, Wunnapuk K. An LC-MS/MS method for creatine and creatinine analysis in paraquat-intoxicated patients. Journal of Environmental Science and Health, Part B 2019;doi:10.1080/03601234.2019.1690342 [Epub ahead of print]

Tremonti C and Haber P. Long acting depot buprenorphine is a new treatment option for opioid dependence. Modern Medicine, in press 2019.

Wijerathna TM, Gawarammana IB, Mohamed F, Dissanayake DM, Dargan PI, Chathuranga U, Jayathilaka C, Buckley NA. Epidemiology, Toxicokinetics and biomarkers after self poisoning with Gloriosa superba. Clinical Toxicology 2019;57(11):1080-86. doi:10.1080/15563650.2019.1581939 IF:4.398

Winter DT, Geiger B, Day CA. (2019). A scoping review of reimbursement practices for substance use research participation in the Australian context (Paper 75). Drug and Alcohol Review, 38 (Suppl. 1): S106. DOI: 10.1111/dar.12991

Wong A, Isbister GK, McNulty R, Chiew AL, Page CB, Greene SL, Gunja N, Buckley NA, Graudins A. Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study). EClinical Medicine (accepted Feb 8th 2020)

Wylie CE, Cairns R, Brown JA, Buckley NA. Human exposures to veterinary pharmaceutical products reported to Australia's largest Poison Information Centre. Clinical Toxicology 2019; 57(10):855-866. doi:10.1080/15563650.2019.1572180 IF:4.398

Zamani N, Buckley NA, Hassanian-Moghaddam H. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a Phase II pilot study. Critical Care 2020; 24:44. doi: 10.1186/s13054-020-2740-y. IF:6.959

Zheng D, Narayan SW, Zoega H, Litchfield M, Buckley NA, Pearson SA, Schaffer AL. Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: a population-based analysis to inform the current policy debate. Pharmacoepidemiology and Drug Safety 2019; 28:521-527. doi: 10.1002/pds.4755. IF:2.870

Drug Health Services Research

Key Research Areas

Selected Grants

Our Publications

2021

Drug Health Services Research

Drug Health Services Research

Our Organisation

Make a Donation

Our Hospitals

Right to Information

Plans

Publications

Quick Links